Cancer News

Hodgkins Lymphoma News

Sorry, there are no news articles available for Hodgkins Lymphoma.

Latest Hodgkins Lymphoma News By Stage

Sorry, there are no articles available for this cancer stage.

More A

Acute Lymphoblastic Leukemia

Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients May Benefit from Sprycel/Chemotherapy Combination (July 28, 2010)

The initial report of a Phase II study evaluating Sprycel® (dasatinib) combined with chemotherapy for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) indicates that 94% of patients achieve a complete remission.... Continue Reading

Study Evaluates Anthracycline-related Heart Problems in Childhood Cancer Survivors (May 28, 2010)

Children with particular variants of drug-metabolizing genes may be more likely than other children to develop heart problems after low doses of anthracycline chemotherapy. The results of this study will be presented at the 2010 annual meeting of the... Continue Reading

Study Evaluates Long-term Efficacy of Peripheral Blood Stem Cell Transplant Versus Bone Marrow Transplant (April 30, 2010)

For leukemia patients who undergo allogeneic stem cell transplantation, 10-year results indicate that bone-marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) produce similar rates of overall and leukemia-free survival.... Continue Reading

Eliminating Preventive Radiation May Benefit Children with ALL (June 26, 2009)

Eliminating Preventive Radiation May Benefit Children with ALL Children with acute lymphoblastic leukemia (ALL) who are treated with effective, risk-adjusted chemotherapy regimens have good outcomes and may safely be able to avoid preventive radiation... Continue Reading

Developments in the Treatment of Acute Lymphoblastic Leukemia: Update from ASH 2008 (March 8, 2009)

Developments in the Treatment of Acute Lymphoblastic Leukemia: Update from ASH 2008 Several studies presented at the 2008 American Society of Hematology (ASH) meeting focused on improving the outcome of acute lymphoblastic leukemia (ALL) in children and... Continue Reading

More Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Mylotarg Withdrawn from Market in United States (June 23, 2010)

Mylotarg® (gemtuzumab ozogamicin), a drug used for the treatment of acute myeloid leukemia (AML), will be withdrawn from the U.S. market following a recent clinical trial that raised new concerns about safety and failed to demonstrate clinical benefit. Mylotarg... Continue Reading

Study Evaluates Long-term Efficacy of Peripheral Blood Stem Cell Transplant Versus Bone Marrow Transplant (April 30, 2010)

Stem Cell Transplants Effective for Breast Cancer Survivors with Secondary Leukemia (July 20, 2009)

Stem cell transplantation is an effective treatment option for breast cancer survivors who develop acute leukemia or myelodysplasia following adjuvant chemotherapy, according to the results of a study published in the Annals of Oncology.[1] Breast cancer... Continue Reading

Allogeneic Stem Cell Transplantation Improves Survival for Intermediate and Poor-risk AML (July 10, 2009)

Allogeneic stem cell transplantation during first complete remission improves relapse-free and overall survival in patients with intermediate and poor-risk acute myeloid leukemia (AML), according to the results of a study published in the Journal of the... Continue Reading

Compressed Dose-dense Induction with S-HAM Effective and Less Toxic for AML Patients (May 5, 2009)

The dose-dense induction regimen S-HAM (sequential high-dose cytarabine [Cytosar®] and mitoxantrone [Novantrone®] followed by Neulasta® [pegfilgrastim]) delivered in two induction cycles over 11-12 days instead of 25-29 days is highly effective... Continue Reading

More Acute Myeloid Leukemia

Acute Promyelocytic Leukemia

Sorry, there are no articles available for this cancer stage.

More Acute Promyelocytic Leukemia

Adjuvant (I-III, A-C) Colon Cancer

Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)

Patients undergoing colorectal surgery are reported to experience an increased incidence of surgical-site infection with the addition of a gentamicin-collagen sponge enclosed at the surgery site. These findings were recently published in the New England... Continue Reading

Potential Role for Oncotype DX Colon Cancer Test in Stage III Cancer (June 10, 2010)

The Oncotype DX® colon cancer test, which is currently available for treatment planning in Stage II colon cancer, may also predict recurrence risk in Stage III colon cancer. These results were presented at the 2010 annual meeting of the American Society... Continue Reading

Erbitux Does Not Improve Survival in Stage III Colon Cancer with Normal KRAS (June 8, 2010)

The addition of Erbitux® (cetuximab) to standard adjuvant chemotherapy in patients with stage III colon cancer who have normal KRAS gene activity does not improve survival, according to the results of a Phase III study presented at the 2010 annual meeting... Continue Reading

Oncotype DX® Predicts Recurrence Risk in Stage II Colon Cancer (January 22, 2010)

Among patients with Stage II colon cancer, use of the newly available Oncotype DX® colon cancer test provides information about the risk of cancer recurrence and may help guide treatment decisions. These results were presented at the 2010 ASCO Gastrointestinal... Continue Reading

Physical Activity Improves Survival of Men with Localized Colorectal Cancer (December 23, 2009)

Men who report the most physical activity after a diagnosis of non-metastatic colorectal cancer have a lower risk of death than men who report the least activity. These results were published in the Archives of Internal Medicine. There are over 10 million... Continue Reading

More Adjuvant (I-III, A-C) Colon Cancer

Adult Acute Lymphoblastic Leukemia

Sorry, there are no articles available for this cancer stage.

More Adult Acute Lymphoblastic Leukemia

Advanced Stage Hodgkin's Lymphoma

Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)

Hodgkin’s Survivors at Increased Risk of Stroke Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute. Hodgkin’s... Continue Reading

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma (March 8, 2009)

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics... Continue Reading

Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer (March 8, 2009)

Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer. Hodgkin’s lymphoma is a cancer... Continue Reading

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia (March 8, 2009)

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia At the 2008 meeting of the American Society of Clinical Oncology (ASCO), there were more than 100 abstracts devoted to the treatment of... Continue Reading

More Advanced Stage Hodgkin's Lymphoma

Advisory Complementary Alternative Medicine

Combination of Herceptin® with Non–anthracycline-based Chemotherapy Appears to Be Effective (December 15, 2009)

Among women with early, HER2-positive breast cancer, the addition of Herceptin® (trastuzumab) to adjuvant chemotherapy reduces the risk of cancer recurrence and improves survival. Herceptin provides a benefit in combination with either anthracycline-... Continue Reading

More Advisory Complementary Alternative Medicine

Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma

Advances in the Treatment of Aggressive Non-Hodgkin’s Lymphoma (March 8, 2009)

Advances in the Treatment of Aggressive Non-Hodgkin’s Lymphoma A Report from the 2008 Meeting of the American Society of Hematology Rituxan and Intensive HyperCVAD Chemotherapy for Mantle Cell Lymphoma Mantle cell lymphoma is a subset of non-Hodgkin’s... Continue Reading

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (March 8, 2009)

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology The 2008 ASH meeting featured several reports of new agents that are showing promise in the treatment of Non-Hodgkin’s... Continue Reading

Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma (March 8, 2009)

Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma Relative dose intensity (RDI) remains a key factor in the outcomes of patients with non-Hodgkins lymphoma (NHL). These results have been validated in several multicenter clinical... Continue Reading

ER-CHOP Promising for Diffuse Large B-Cell NHL (March 8, 2009)

ER-CHOP Promising for Diffuse Large B-Cell NHL The treatment combination consisting of epratuzumab, Rituxan® (rituximab), and the chemotherapy combination referred to as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) provides high... Continue Reading

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma (March 8, 2009)

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma Zevalin® (Yttrium-90 [(90)Y] ibritumomab tiuxetan) appears highly effective in the treatment of primary cutaneous B-cell lymphoma (PCBCL). The details of this study appeared in an early online... Continue Reading

More Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma

All Cancer Types

Guidelines Encourage Exercise During and After Cancer Treatment (June 7, 2010)

Cancer patients who’ve been told to rest and avoid exercise can—and should—find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology... Continue Reading

Cancer Caregivers Devote Substantial Time and Effort (September 9, 2009)

On average, informal caregivers of cancer patients devote more than eight hours per day to caregiving. These results were published in Cancer. Informal caregiving is an important part of cancer management. Family and friends often spend considerable time... Continue Reading

September Is National Leukemia and Lymphoma Awareness Month (August 28, 2009)

As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated... Continue Reading

More All Cancer Types

Allogeneic Stem Cell Transplant

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer. Stem cell transplantation involves... Continue Reading

Statins May Reduce Acute Graft-versus-host Disease (March 8, 2009)

Statins May Reduce Acute Graft-versus-host Disease Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants.... Continue Reading

Stem Cell Transplant Procedures Vary Throughout the World (March 8, 2009)

Stem Cell Transplant Procedures Vary Throughout the World Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).... Continue Reading

More Allogeneic Stem Cell Transplant

Alphabetical Sort

Sorry, there are no articles available for this cancer stage.

More Alphabetical Sort

Alternative Medical Systems Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More Alternative Medical Systems Complementary Alternative Medicine

Anal Cancer

Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)

The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.[1] Human... Continue Reading

More Anal Cancer

Autologous Stem Cell Transplant

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Stem Cell Transplant Procedures Vary Throughout the World (March 8, 2009)

More Autologous Stem Cell Transplant

Sorry, there are no articles available for this cancer stage.

More B

Barrett's Esophagus Esophageal Cancer

Sorry, there are no articles available for this cancer stage.

More Barrett's Esophagus Esophageal Cancer

Biologic-Orthomolecular Therapies Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More Biologic-Orthomolecular Therapies Complementary Alternative Medicine

Biological Therapy

Sorry, there are no articles available for this cancer stage.

More Biological Therapy

Bladder Cancer

Components of Processed Meat May Increase Risk of Bladder Cancer (August 10, 2010)

People who consume a large amount of nitrite and nitrate from processed meat may be at an increased risk for developing bladder cancer, according to a study published in Cancer. Bladder cancer is diagnosed in as many as 60,000 individuals annually in... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

Painters May Have Higher Risk of Bladder Cancer (July 29, 2010)

Occupational exposures appear to increase bladder cancer risk in painters, according to a study published in Occupational and Environmental Medicine. Workers in certain occupations may face an increased risk of cancer due to exposures that they encounter... Continue Reading

Exposure to Aromatic Amines Poses Long-term Risk of Bladder Cancer (June 25, 2010)

Workers exposed to aromatic amines continued to experience an increased risk of bladder cancer even 30 years after exposure, according to the results of a follow-up study published in the Journal of the National Cancer Institute.[1] Aromatic amines are... Continue Reading

Vitamins C, D, and E Don’t Reduce Risk of Bladder Cancer (June 7, 2010)

Long-term use of vitamin C, vitamin D, or vitamin E does not appear to reduce the risk of bladder cancer. These results were presented at the 2010 annual meeting of the American Urological Association. Each year in the United States, close to 53,000 men... Continue Reading

More Bladder Cancer

Bone Cancer

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone (June 5, 2009)

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone In a Phase II clinical trial, 86% of patients with giant cell tumor of the bone responded to treatment with the investigational targeted therapy denosumab. These results were presented... Continue Reading

More Bone Cancer

Brain Cancer

Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)

Recent findings indicate that children who are exposed to radiofrequency fields from cell phone towers before birth do not have an increased risk of early childhood cancer. This study was published in the British Medical Journal. The health effects—notably,... Continue Reading

Novel Approach Shows Promise for Glioblastoma (June 16, 2010)

A new non-invasive treatment has shown promising results in patients with recurrent glioblastoma when compared with the best standard chemotherapy regimens, according to the results of a Phase III study presented at the 2010 annual meeting of the American... Continue Reading

Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme (June 14, 2010)

Maintenance therapy with rindopepimut (CDX-110) combined with Temodar® (temozolomide) resulted in a 70% progression-free rate at 5.5 months for newly diagnosed patients with glioblastoma multiforme (GBM). These findings were recently presented at the... Continue Reading

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

Late recurrence of childhood cancers appears to occur most often in Ewing’s sarcoma and astrocytoma, according to the results of a study published in the Journal of the National Cancer Institute. As cancer treatment has improved and evolved, the number... Continue Reading

More Brain Cancer

Breast Cancer

Alcohol Linked with Lobular Breast Cancer (September 3, 2010)

Although alcohol is a well-established risk factor for breast cancer, it may be more strongly linked with lobular breast cancer than with ductal breast cancer. These results were published in the Journal of the National Cancer Institute. Research suggests... Continue Reading

Additional Research on Menopausal Hormone Therapy and Breast Cancer (August 24, 2010)

A recent study of menopausal hormone therapy and risk of breast cancer reported that risk may vary by body weight and the type of hormone therapy. These results were published in Cancer Epidemiology, Biomarkers, & Prevention. As women reach menopause... Continue Reading

Mediterranean Diet May Lower Breast Cancer Risk (August 16, 2010)

Postmenopausal women who consume a traditional Mediterranean diet may have a lower risk for breast cancer, according to a study published in the American Journal of Clinical Nutrition. A traditional Mediterranean diet—one that is rich in fish, olive... Continue Reading

Mediterranean Diet May Lower Breast Cancer Risk (August 16, 2010)

Study Evaluates Impact of Lymph Node Removal in Early-stage Breast Cancer (August 13, 2010)

Early-stage breast cancer patients without evidence of cancer in their sentinel lymph node who did not have additional lymph nodes removed report fewer side effects to the arm and breast than patients who undergo additional lymph node removal. These findings... Continue Reading

More Breast Cancer

Sorry, there are no articles available for this cancer stage.

More C

Cancer Dictionary

Sorry, there are no articles available for this cancer stage.

More Cancer Dictionary

Carcinoma In Situ Breast cancer

Racial Disparity in Breast Cancer Outcomes Among Underinsured (June 30, 2010)

Underinsured African-Americans have worse breast cancer survival outcomes than their underinsured White counterparts, according to the results of a study published early online in the Journal of the National Caner Institute.[i] The disparity in breast... Continue Reading

Young Women with DCIS Have Higher Risk of Recurrence (October 12, 2009)

After treatment of breast ductal carcinoma in situ (DCIS) with breast-conserving surgery and radiation therapy, women age 44 or younger have a higher rate of recurrence than older women. These results were presented at the ASCO 2009 Breast Cancer Symposium. Ductal... Continue Reading

Lifestyle Factors Increase Risk of Second Breast Cancer (September 24, 2009)

Obesity, alcohol consumption, and smoking significantly increase the risk of second breast cancers among breast cancer survivors, according to the results of a study published in the Journal of Clinical Oncology.[1] Approximately 200,000 women are diagnosed... Continue Reading

Surgical Decision-making in Early-stage Breast Cancer (September 15, 2009)

Patients with early-stage breast cancer who take an active role in decision-making tend to opt for mastectomy over lumpectomy, despite the fact that the procedures have been shown to produce equivalent outcomes, according to the results of a study published... Continue Reading

Mammography Screening Important After Lumpectomy for DCIS (July 17, 2009)

Surveillance mammography after breast-conserving surgery for ductal carcinoma in situ (DCIS) appears to decline over time, despite the increased risk of invasive cancer, according to the results of a study published in the Journal of Clinical Oncology.[1] Ductal... Continue Reading

More Carcinoma In Situ Breast cancer

Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)

Results from a recent international study indicate that the vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) protects against genital warts and low-grade precancerous changes to the cervix, vulva, and vagina.... Continue Reading

Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)

Apparently, old habits die hard: less than one-third of physicians report compliance with the updated guidelines for cervical cancer screening that suggest longer intervals between screening for women with normal test results. The results of this survey... Continue Reading

More Than Half of Young Adults in New Relationships Infected with HPV (April 26, 2010)

More than half of young adults in a new sexual relationship are infected with human papillomavirus (HPV), and of those 44% were infected with an HPV type that causes cancer, according to the results of a groundbreaking study called the HITCH Cohort... Continue Reading

ACOG Updates Cervical Cancer Screening Guidelines (November 20, 2009)

The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These... Continue Reading

More Cervical Cancer

Chemotherapy

Sorry, there are no articles available for this cancer stage.

More Chemotherapy

Childhood Acute Lymphoblastic Leukemia

Sorry, there are no articles available for this cancer stage.

More Childhood Acute Lymphoblastic Leukemia

Chronic Lymphoblastic Leukemia

Arzerra™ Approved for Refractory Chronic Lymphocytic Leukemia (October 28, 2009)

The targeted therapy Arzerra™ (ofatumumab) has been granted accelerated approval by the U.S. Food and Drug Administration for treatment of patients with chronic lymphocytic leukemia (CLL) that is refractory to Fludara® (fludarabine) and Campath® (alemtuzumab). Chronic... Continue Reading

FCR-Lite Is Safe and Effective in Previously Untreated CLL (March 8, 2009)

FCR-Lite Is Safe and Effective in Previously Untreated CLL FCR-Lite, a drug regimen that consists of Fludara® (fludarabine), Cytoxan® (cyclophosphamide), and Rituxan® (rituximab), is highly effective in previously untreated patients with chronic lymphocytic... Continue Reading

Sequential Treatment with Fludara®, Cytoxan®, and Rituxan® Produces High-quality Responses in CLL (March 8, 2009)

Sequential Treatment with Fludara®, Cytoxan®, and Rituxan® Produces High-quality Responses in CLL Patients with chronic lymphocytic leukemia (CLL) treated with Fludara® (fludarabine), followed by consolidation with Cytoxan® (cyclophosphamide), and... Continue Reading

Revlimid® Shows Promise as First-line Therapy of CLL (March 8, 2009)

Revlimid® Shows Promise as First-line Therapy of CLL According to the results of two studies presented at the 2008 annual meeting of the American Society of Hematology (ASH), Revlimid® (lenalidomide) appears to be effective for the initial treatment... Continue Reading

Arzerra™ Effective For CLL (March 8, 2009)

Arzerra™ Effective For CLL Arzerra™ (ofatumumab), a human anti-CD20 monoclonal antibody, is effective for the treatment of patients with refractory chronic lymphocytic leukemia (CLL), according to the results of a study presented at the annual meeting... Continue Reading

More Chronic Lymphoblastic Leukemia

Chronic Lymphocytic Leukemia

Rituxan Approved for Chronic Lymphocytic Leukemia (February 24, 2010)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Rituxan® (rituximab) to include the treatment of certain patients with chronic lymphocytic leukemia. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia with... Continue Reading

Arzerra™ Approved for Refractory Chronic Lymphocytic Leukemia (October 28, 2009)

Abnormal Cells Identified in Blood Years Before Diagnosis of CLL (March 9, 2009)

According to the results of a study published in the New England Journal of Medicine, chronic lymphocytic leukemia (CLL) appears to be preceded by a condition known as monoclonal B-cell lymphocytosis (MBL). Chronic lymphocytic leukemia is the most common... Continue Reading

More Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Tasigna Approved for Initial Treatment of Chronic Myeloid Leukemia (June 22, 2010)

The U.S. Food and Drug Administration has expanded the approval of Tasigna® (nilotinib) to include the initial treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. Each year in the United States, approximately... Continue Reading

Sprycel May Be More Effective than Gleevec for Initial Treatment of CML (June 7, 2010)

In the initial treatment of chronic myeloid leukemia (CML), Sprycel® (dasatinib) produces higher response rates than Gleevec® (imatinib). These results were presented at the 2010 annual meeting of the American Society of Clinical Oncology. Each year... Continue Reading

Study Evaluates Long-term Efficacy of Peripheral Blood Stem Cell Transplant Versus Bone Marrow Transplant (April 30, 2010)

Tasigna May Be More Effective than Gleevec for Initial Treatment of CML (January 28, 2010)

In the initial treatment of chronic myeloid leukemia (CML), Tasigna® (nilotinib) appears to produce higher response rates than Gleevec® (imatinib) 400 mg/day. These results were presented at the 2009 meeting of the American Society of Hematology... Continue Reading

Sprycel® Superior to High-dose Gleevec® in Gleevec-resistant CML (July 1, 2009)

Sprycel® (dasatinib) produces a higher response rate and improves progression-free survival in patients with chronic myeloid leukemia (CML) who have grown resistant to Gleevec® (imatinib), according to the results of a study published early online in... Continue Reading

More Chronic Myeloid Leukemia

Clinical Trials Database

Sorry, there are no articles available for this cancer stage.

More Clinical Trials Database

Colon Cancer

Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)

Screening Rates Among Older Americans (July 15, 2010)

More older Americans are undergoing screening for colon cancer, but the rates for breast cancer screening remain the same, according to a government report released on July 6, 2010.[1] The best “treatment” of cancer is preventing its occurrence in... Continue Reading

Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)

Radioembolization plus the chemotherapy agent fluorouracil slows cancer progression for colorectal cancer patients whose disease has progressed following prior treatment with chemotherapy and have metastases limited to the liver. These findings were recently... Continue Reading

Potential Role for Oncotype DX Colon Cancer Test in Stage III Cancer (June 10, 2010)

Erbitux Does Not Improve Survival in Stage III Colon Cancer with Normal KRAS (June 8, 2010)

More Colon Cancer

Complementary Alternative Medicine

Fish Oil Linked to Reduction in Breast Cancer Risk (July 9, 2010)

A recent study suggests that regular use of fish oil supplements may reduce the risk of breast cancer. These findings were published in the journal of Cancer Epidemiology, Biomarkers & Prevention.[1] Dietary supplements are a booming business—Americans... Continue Reading

Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover (March 8, 2009)

Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover March 17, 2008 Press Contact: Diana Price dprice@omnihealthmedia.com (208) 727-2108, ext. 202 March 17, 2008-Zahn Appears on Women&Cancer cover, Spring 2008 News anchor... Continue Reading

More Complementary Alternative Medicine

Corticosteroid

Sorry, there are no articles available for this cancer stage.

More Corticosteroid

Sorry, there are no articles available for this cancer stage.

More D

Drug Dictionary

Sorry, there are no articles available for this cancer stage.

More Drug Dictionary

Sorry, there are no articles available for this cancer stage.

More E

Early Stage Hodgkin's Lymphoma

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (August 27, 2010)

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published... Continue Reading

Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers Industrial workers who are exposed to formaldehyde may be at an increased risk of dying from blood and lymphatic cancers, particularly myeloid leukemia but also Hodgkin’s lymphoma... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma (March 8, 2009)

More Early Stage Hodgkin's Lymphoma

Early Stage I-II (A-B) Prostate Cancer

Death from Other Causes Among Men with Early-stage Prostate Cancer (August 26, 2010)

Among men with early-stage prostate cancer, assessment of other health problems may help guide prostate cancer treatment decisions; men who are likely to die of causes other than prostate cancer may not benefit from aggressive prostate cancer treatment.... Continue Reading

Study Explores Prostate Cancer Among Men with Low PSA Levels (July 30, 2010)

In a large U.S. cancer database, 14% of prostate cancer diagnoses occurred among men with a prostate-specific antigen (PSA) level of 4.0 ng/mL or lower. More than half of these men had cancer that was considered “low-risk,” but roughly three-quarters... Continue Reading

Statins May Reduce Risk of Prostate Cancer Recurrence (July 2, 2010)

Statin use may reduce the risk of prostate cancer recurrence among men who have undergone a radical prostatectomy. These findings were recently published in the journal Cancer.[1] Statins are cholesterol-lowering drugs; they are the most commonly prescribed... Continue Reading

Watchful Waiting May Be Sufficient in Low-risk Prostate Cancer (June 30, 2010)

Active surveillance—sometimes referred to as “watchful waiting”—may be acceptable treatment for low-risk prostate cancer, according to the results of a study published early online in the Journal of the National Cancer Institute.[1] Men with early-stage... Continue Reading

External Beam Radiation Raises Risk of Hip Fracture in Prostate Cancer (June 8, 2010)

Men treated with external beam radiation therapy for prostate cancer may have an increased risk of hip fracture, according to data presented at the 2010 Annual Scientific Meeting of the American Urological Association. Radiation therapy is a commonly... Continue Reading

More Early Stage I-II (A-B) Prostate Cancer

Esophageal Cancer

Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer (August 23, 2010)

Oral bisphosphonates—drugs commonly used to prevent or treat osteoporosis—do not appear to increase the risk of esophageal cancer. These results were published in the Journal of the American Medical Association. Osteoporosis—a condition characterized... Continue Reading

Chemoradiotherapy plus Surgery Improves Esophageal Cancer Survival (July 19, 2010)

Among patients with cancer of the esophagus or esophagogastric junction, treatment with chemotherapy and radiation therapy prior to surgery resulted in better overall survival than surgery alone. The results of this Phase III clinical trial were presented... Continue Reading

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma. In fact, there was a suggestion that people with the... Continue Reading

Depression May Persist With Metastatic Cancer (May 27, 2010)

A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

According to estimates from the American Institute for Cancer Research (AICR), excess body weight may be responsible for more than 100,000 new cancer diagnoses each year in the United States. Excess body weight is increasingly recognized as a risk factor... Continue Reading

More Esophageal Cancer

Ewing's Sarcoma Overview

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

More Ewing's Sarcoma Overview

Extensive Lung Cancer - Small Cell

Depression May Persist With Metastatic Cancer (May 27, 2010)

November Is National Lung Cancer Awareness Month (November 6, 2009)

As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information... Continue Reading

Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer (July 22, 2009)

Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy alone. The results of this study were published... Continue Reading

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer (March 8, 2009)

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination of VePesid® (etoposide) and Platinol® (cisplatin).... Continue Reading

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (March 8, 2009)

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were recently published in the Journal of... Continue Reading

More Extensive Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More F

Follicular Lymphoma

Sorry, there are no articles available for this cancer stage.

More Follicular Lymphoma

Sorry, there are no articles available for this cancer stage.

More G

Gastric Cancer

Afinitor Promising in Treatment of Advanced Gastric Cancer (July 23, 2010)

Afinitor® (everolimus) may be a promising treatment option for patients with metastatic gastric cancer who have undergone previous treatment, according to a study published in the Journal of Clinical Oncology. Afinitor is an oral targeted therapy that... Continue Reading

Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)

Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)

Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the... Continue Reading

More Gastric Cancer

Gene Therapy

Sorry, there are no articles available for this cancer stage.

More Gene Therapy

General

Long-term Cardiac Risks Among Childhood Cancer Survivors (August 5, 2010)

Twenty-seven percent of survivors of childhood cancers may have long-term heart complications, according to findings reported in the Archives of Internal Medicine. The survival rate for childhood cancer is high, with 80% of children and adolescents surviving... Continue Reading

Study Evaluates Long-term Side Effects of Pelvic Radiation to Treat Childhood Cancer (August 2, 2010)

The offspring of women who underwent pelvic radiation before puberty for the treatment of childhood cancer are at increased risk of stillbirth and neonatal death. These findings were recently published in the journal The Lancet.[1] The survival rate for... Continue Reading

Neoadjuvant Chemotherapy Regimen Promising for Metastatic Penile Cancer (July 28, 2010)

A neoadjuvant (before surgery) combination of Taxol® (paclitaxel), Ifex® (ifosfamide), and Platinol® (cisplatin) produced clinically significant responses in patients with bulky regional lymph node metastases from penile cancer, according to the results... Continue Reading

Childhood Cancer Survivors Experience Elevated Risk of Premature Death Years after Diagnosis (July 27, 2010)

Childhood cancer survivors may experience a persistently higher risk of premature death due to disease compared with the general population. These findings were recently published in the Journal of the American Medical Association.[1] The survival rate... Continue Reading

Twenty Possible Causes of Cancer (July 26, 2010)

The American Cancer Society along with three federal agencies have identified 20 potential causes of cancer that warrant further investigation, according to the results of a study published in Environmental Health Perspectives.[1] Many chemicals and environmental... Continue Reading

More General

General Bone Cancer

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone (June 5, 2009)

Denosumab Reduces the Risk of Bone Fractures (March 8, 2009)

Denosumab Reduces the Risk of Bone Fractures According to the results of a Phase III clinical trial, treatment with denosumab significantly reduces the risk of vertebral and hip fractures among postmenopausal women with osteoporosis. These results were... Continue Reading

More General Bone Cancer

General Brain Cancer

Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)

Novel Approach Shows Promise for Glioblastoma (June 16, 2010)

Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme (June 14, 2010)

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

More General Brain Cancer

General Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More General Complementary Alternative Medicine

General Gene Therapy

Sorry, there are no articles available for this cancer stage.

More General Gene Therapy

General Head and Neck Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Mixed Findings on Combination Therapy for Nasopharyngeal Cancer (July 26, 2010)

Results of a Phase III trial indicate that treating nasopharyngeal cancer with a combination of radiation and chemotherapy can significantly reduce disease progression but that the combination may also increase the rate of death from other causes. These... Continue Reading

Coffee May Reduce Head and Neck Cancer Risk (June 24, 2010)

Drinking caffeinated coffee may reduce the risk of cancers of the oral cavity (mouth) and pharynx. These results were published in Cancer Epidemiology, Biomarkers, and Prevention. Head and neck cancers originate in the tissues in or around the mouth,... Continue Reading

Chemotherapy plus Radiation Doubles Survival Time in Advanced Head and Neck Cancer (December 9, 2009)

The addition of chemotherapy to radiation therapy doubles median survival time as well as event-free survival in patients with locally advanced head and neck cancer who have not undergone surgery, according to the results of a study published in the Lancet... Continue Reading

Uninsured Have Worse Head and Neck Cancer Survival (November 26, 2009)

Even after accounting for stage at diagnosis and several other prognostic factors, head and neck cancer patients who are uninsured or covered by Medicaid or Medicare disability (Medicare under age 65) have worse survival than patients with private insurance.... Continue Reading

More General Head and Neck Cancer

General HIV Related Cancers

Study Evaluates Impact of Highly Active Antiretroviral Therapy (HAART) on Cancer Risk in HIV-infected Men (August 10, 2010)

Researchers reported that men infected with human immunodeficiency virus (HIV) are still at an increased risk of lymphoma, Kaposi’s sarcoma (KS), and anal cancer despite the introduction of highly active antiretroviral therapy (HAART). These findings... Continue Reading

More General HIV Related Cancers

General Lung Cancer

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Individuals with high blood levels of vitamin B6 may be less likely to develop lung cancer compared with their counterparts with lower vitamin B6 levels, according to the results of a study published in the Journal of the American Medical Association.[1] Lung... Continue Reading

Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)

It appears that angiotensin-receptor blockers (ARBs), a widely used class of blood pressure drugs, may slightly increase the risk of cancer. These findings were published in the Lancet Oncology. Angiotensin-receptor blockers work by blocking angiotensin... Continue Reading

Anti-estrogens May Reduce Risk of Lung Cancer Death (December 14, 2009)

Anti-estrogens (such as tamoxifen [Nolvadex®]) used as treatment for breast cancer may also reduce the risk of death from lung cancer, according to the results of a study presented at the 2009 San Antonio Breast Cancer Symposium.[1] A majority of breast... Continue Reading

November Is National Lung Cancer Awareness Month (November 6, 2009)

Lung Cancer: Still Number One (October 20, 2009)

Lung cancer remains the leading cause of cancer death in both men and women. By Kari Bohlke, ScD In 1987 lung cancer surpassed breast cancer as the leading cause of cancer deaths in U.S. women.[1] Lung cancer kills more women than breast cancer, ovarian... Continue Reading

More General Lung Cancer

General Malignant Mesothelioma

MVP Does Not Provide Benefit in Mesothelioma Patients (May 21, 2008)

MVP Does Not Provide Benefit in Mesothelioma Patients The chemotherapy agent Navelbine® (vinorelbine) may improve outcomes for patients with malignant pleural mesothelioma. However, the combination chemotherapy regimen referred to as MVP (mitoxantrone,... Continue Reading

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (February 8, 2008)

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. These findings were... Continue Reading

More General Malignant Mesothelioma

General Myelodysplastic Syndrome

Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes (March 6, 2009)

According to the results of a Phase III clinical trial, treatment with Vidaza® (azacitidine) results in better survival than conventional care among patients with higher-risk myelodysplastic syndromes (MDS). These results were published in Lancet Oncology. Myelodysplastic... Continue Reading

The American Society of Clinical Oncology 2008: Highlights of Treatment of Hematological Malignancies (January 30, 2009)

The American Society of Clinical Oncology 2008: Highlights of Treatment of Hematological Malignancies The 2008 annual meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, again revealed advances in the treatment of... Continue Reading

New Risk Model for MDS Applies to All Stages of Disease (December 31, 2008)

New Risk Model for MDS Applies to All Stages of Disease A new risk model for myelodysplastic syndrome (MDS) provides survival projections for all stages of the disease and has proven superior to the International Prognostic Scoring System (IPSS) that... Continue Reading

Older Age Does Not Affect Survival in Patients with AML or MDS Who Undergo Mini-transplants (December 30, 2008)

Older Age Does Not Affect Survival in Patients with AML or MDS Who Undergo Mini-transplants Age should not be a barrier for non-myeloablative allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome... Continue Reading

Vidaza® Approved for High-risk MDS (August 22, 2008)

Vidaza® Approved for High-risk MDS The US Food and Drug Administration (FDA) has approved Vidaza® (azacitadine) for the treatment of high-risk myelodysplastic syndromes. Vidaza is already approved for MDS that is categorized into all five French American... Continue Reading

More General Myelodysplastic Syndrome

General Neuroblastoma

Genetic Variation Associated with Risk of Neuroblastoma (March 8, 2009)

Genetic Variation Associated with Risk of Neuroblastoma Individuals with a common genetic variation (change in DNA) on the chromosome band 6p22 have a significantly increased risk of developing neuroblastoma, as well as an increased risk for disease relapse... Continue Reading

More General Neuroblastoma

General Renal Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

Some Chinese Herbs May Increase Risk of Urinary Tract Cancer (February 18, 2010)

The use of Chinese herbal products that contain aristolochic acid is associated with an increased risk of urinary tract cancer, according to the results of a study published in the Journal of the National Cancer Institute.[1] Previous research has... Continue Reading

Votrient Improves Progression-free Survival in Advanced Kidney Cancer (January 27, 2010)

Compared with a placebo, treatment with the oral, targeted drug Votrient® (pazopanib) delays progression of advanced kidney cancer. The results of this Phase III clinical trial were published in the Journal of Clinical Oncology. The kidneys are filled... Continue Reading

Sterotactic Radiosurgery Alone Is Preferred Treatment for Newly Diagnosed Brain Metastases (December 9, 2009)

Patients with newly diagnosed brain metastases who undergo sterotactic radiosurgery plus whole-brain radiation therapy experience significant memory loss; therefore, stereotactic radiosurgery alone is the preferred method of treatment for these patients,... Continue Reading

More General Renal Cancer

General Retinoblastoma

Retinoblastoma Survivors Face Risk of Second Cancers (March 8, 2009)

Retinoblastoma Survivors Face Risk of Second Cancers A study that followed retinoblastoma survivors for up to 61 years reported a high risk of second cancers among survivors of hereditary retinoblastoma. These results were published in the Journal of... Continue Reading

Chemotherapy for Retinoblastoma Delivered Directly into Eye May Save Eye (March 8, 2009)

Chemotherapy for Retinoblastoma Delivered Directly into Eye May Save Eye Chemotherapy delivered directly into the artery of the eye may save the eyeball in children with retinoblastoma. These results were recently published in an early online publication... Continue Reading

More General Retinoblastoma

General Sarcoma

Targeted Heat Therapy Improves Outcomes for Soft Tissue Sarcoma (September 30, 2009)

A new technique called regional hyperthermia (RHT) makes chemotherapy more effective and improves outcomes in patients with soft tissue sarcoma, according to the results of a study presented on September 22, 2009 at Europe’s largest cancer congress,... Continue Reading

Gleevec® Approved for Adjuvant Treatment of Gastrointestinal Stromal Tumors (March 8, 2009)

Gleevec® Approved for Adjuvant Treatment of Gastrointestinal Stromal Tumors The U.S. Food and Drug Administration has expanded the approval of Gleevec® (imatinib mesylate) to include the adjuvant (post-surgery) treatment of Kit-positive gastrointestinal... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Sarcomas (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Sarcomas Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

PET Scan More Accurate Predictor of Treatment Response for Soft Tissue Sarcomas (March 8, 2009)

PET Scan More Accurate Predictor of Treatment Response for Soft Tissue Sarcomas Positron emission tomography (PET) scans were found to be significantly more accurate than standard methods in judging response to first-line treatment for high-grade soft... Continue Reading

Sutent® Linked with Heart Problems (March 8, 2009)

Sutent® Linked with Heart Problems According to the results of a study published in the Lancet, treatment with Sutent® (sunitinib) was linked with the development of heart problems in some patients with metastatic gastrointestinal stromal tumors. Sutent... Continue Reading

More General Sarcoma

General Skin Cancer

HPV Infection May Raise Skin Cancer Risk (July 13, 2010)

It appears that infection with certain types of human papillomavirus (HPV) may be linked with the incidence of squamous cell carcinoma, a form of skin cancer. These findings were recently published in the journal BMJ. There are three main types of cancers... Continue Reading

Indoor Tanning May Be Addictive in Some Individuals (April 30, 2010)

Researchers report that some individuals may meet criteria for addiction to indoor tanning and are more likely to exhibit other addictive behaviors and affective disturbance. These results were recently published in the journal Archives of Dermatology.[1] Each... Continue Reading

Tanning Beds Classified as “Carcinogenic to Humans” (July 30, 2009)

The International Agency for Research on Cancer (IARC) now classifies tanning beds and other UV-emitting tanning devices as Group 1 carcinogens, meaning that there is sufficient evidence to conclude that these devices cause cancer in humans.[1] Use of... Continue Reading

Moh’s Micrographic Surgery More Effective than Excision for Recurrent Basal Cell Carcinoma of the Face (March 8, 2009)

Moh’s Micrographic Surgery More Effective than Excision for Recurrent Basal Cell Carcinoma of the Face Moh’s micrographic surgery (MMS) for the treatment of recurrent basal cell carcinoma (rBCC) of the face results in fewer recurrences than... Continue Reading

Non-melanoma Skin Cancer Associated with Increased Risk of Other Cancers (March 8, 2009)

Non-melanoma Skin Cancer Associated with Increased Risk of Other Cancers Individuals who have been diagnosed with squamous cell or basal cell carcinoma have an increased risk of developing subsequent cancers other than skin cancer. These results were... Continue Reading

More General Skin Cancer

General Thyroid Cancer

Vandetanib Delays Progression of Advanced Medullary Thyroid Cancer (July 16, 2010)

Results of a Phase III clinical trial indicate that the investigational drug vandetanib delays the progression of locally advanced or metastatic medullary thyroid cancer. These results were presented at the 2010 annual meeting of the American Society... Continue Reading

Childhood Cancer Survivors at Risk for Thyroid Cancer (November 2, 2009)

Survivors of childhood cancer are 18 times more likely to develop thyroid cancer than the general population, according to the results of a study published in the International Journal of Cancer.[1] Survivors of childhood cancers are often at risk for... Continue Reading

Thyroid Cancer: It’s Not in Your Head-It’s in Your Neck! (March 8, 2009)

Thyroid Cancer: It’s Not in Your Head-It’s in Your Neck! A thyroid cancer survivor shares valuable information about the disease and insight into the treatment process. It all started with bumps-what I would later learn were actually called... Continue Reading

Nexavar® Provides Anticancer Activity in Advanced Thyroid Cancer (March 8, 2009)

Nexavar® Provides Anticancer Activity in Advanced Thyroid Cancer Nexavar® (sorafenib) provides cancer control among patients with thyroid cancer that has progressed following standard therapy. These results were recently published in the Journal of... Continue Reading

Motesanib Diphosphate Provides Anticancer Activity Among Patients with Progressive Thyroid Cancer (March 8, 2009)

Motesanib Diphosphate Provides Anticancer Activity Among Patients with Progressive Thyroid Cancer The investigative agent motesanib diphosphate (AMG 706) produces a regression of cancer among patients with thyroid cancer that is progressing despite... Continue Reading

More General Thyroid Cancer

General Vaginal Cancer

Tumor Burden in Sentinel Node May Help Stratify High- and Low-risk Vulvar Cancer Patients (June 15, 2010)

Tumor burden in the sentinel node of early-stage vulvar cancer patients appears to be an important prognostic factor. Patients with sentinel-node metastasis larger than 2mm may have a worse prognosis. These findings were recently published in the journal... Continue Reading

Gardasil® Approved for Prevention of Vaginal and Vulvar Cancers (March 8, 2009)

Gardasil® Approved for Prevention of Vaginal and Vulvar Cancers The United States Food and Drug Administration (FDA) has expanded the indication for Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) for the prevention... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading

Aldara™ Effective Alternative to Surgery for Precancerous Changes to Vulva (April 11, 2008)

Aldara™ Effective Alternative to Surgery for Precancerous Changes to Vulva A recently published study in the New England Journal of Medicine reports that topical Aldara™ (imiquimod) may be an effective alternative to surgery for the treatment of precancerous... Continue Reading

More General Vaginal Cancer

Sorry, there are no articles available for this cancer stage.

More H

Hairy Cell Leukemia

Sorry, there are no articles available for this cancer stage.

More Hairy Cell Leukemia

Head and Neck Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Mixed Findings on Combination Therapy for Nasopharyngeal Cancer (July 26, 2010)

Coffee May Reduce Head and Neck Cancer Risk (June 24, 2010)

Chemotherapy plus Radiation Doubles Survival Time in Advanced Head and Neck Cancer (December 9, 2009)

Uninsured Have Worse Head and Neck Cancer Survival (November 26, 2009)

More Head and Neck Cancer

Health and Wellness

Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer (August 23, 2010)

Obesity on the Rise in United States (August 19, 2010)

Rates of obesity are rising among the U.S. population, according to statistics recently released from the Centers for Disease Control and Prevention (CDC). Obesity is a significant public health concern that can raise the risk of several serious health... Continue Reading

Mediterranean Diet May Lower Breast Cancer Risk (August 16, 2010)

Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)

More Health and Wellness

Hepatocellular Carcinoma Liver Cancer

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading

Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)

Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (March 8, 2009)

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular carcinoma (HCC), the most common form of liver... Continue Reading

Nexavar® Improves Survival in Advanced Liver Cancer (March 8, 2009)

Nexavar® Improves Survival in Advanced Liver Cancer The targeted agent Nexavar (sorafenib) is associated with improved survival and doubling of the time to cancer progression for patients with advanced liver cancer. These results were recently published... Continue Reading

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (March 8, 2009)

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver cancer survival rates and may improve chances for... Continue Reading

More Hepatocellular Carcinoma Liver Cancer

Highly Aggressive/High Grade Non-Hodgkin's Lymphoma

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (March 8, 2009)

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma (March 8, 2009)

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma Patients diagnosed with non-Hodgkin’s lymphoma (NHL) who smoke tobacco products and/or drink large quantities of alcohol have a reduced chance of optimal survival.... Continue Reading

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (March 8, 2009)

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma Statins may reduce the effectiveness of Rituxan® (rituximab) in treatment of non-Hodgkin’s lymphoma (NHL), according to a recently published article in PLoS Med (the... Continue Reading

Tobacco and Alcohol May Decrease Survival for Non-Hodgkin’s Lymphoma Patients (March 8, 2009)

Tobacco and Alcohol May Decrease Survival for Non-Hodgkin’s Lymphoma Patients Heavy tobacco smoking and alcohol consumption may be associated with poor survival among patients with Non-Hodgkin’s Lymphoma (NHL). These findings were recently... Continue Reading

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress (March 8, 2009)

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress Patients who have been diagnosed and treated for non-Hodgkin’s lymphoma may have symptoms of post traumatic stress disorder (PTSD). These finding were recently published... Continue Reading

More Highly Aggressive/High Grade Non-Hodgkin's Lymphoma

HIV Related Cancers

Study Evaluates Impact of Highly Active Antiretroviral Therapy (HAART) on Cancer Risk in HIV-infected Men (August 10, 2010)

Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)

More HIV Related Cancers

Hodgkin's Lymphoma

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (August 27, 2010)

Childhood Cancer Survivors Treated with Radiation Therapy at Increased Risk of Death from Heart Disease in Adulthood (March 26, 2010)

A dose of as little as 5 Gy of radiation therapy to the heart for the treatment of childhood cancers results in a significant increase in cardiac death later in life, according to a study recently published in the Journal of Clinical Oncology.[1] Survivors... Continue Reading

Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (September 24, 2009)

Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the results of a study published in Blood.[1] Although children and adolescents with Hodgkin’s lymphoma have an excellent... Continue Reading

Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)

More Hodgkin's Lymphoma

Hormonal Therapy

Sorry, there are no articles available for this cancer stage.

More Hormonal Therapy

Sorry, there are no articles available for this cancer stage.

More I

Indolent/Low Grade Non-Hodgkin's Lymphoma

Maintenance Therapy with Rituxan Prolongs Lymphoma Remission (May 26, 2010)

Among patients with follicular lymphoma who responded to initial treatment with chemotherapy and Rituxan® (rituximab), those who received an additional two years of Rituxan as maintenance therapy remained free of lymphoma progression for longer than... Continue Reading

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma (June 8, 2009)

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma BiovaxID, an individualized tumor-specific protein vaccine, prolongs disease-free survival in patients with advanced follicular lymphoma who experience complete remission... Continue Reading

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (March 8, 2009)

Advances in the Treatment of Low-grade Non-Hodgkin’s Lymphoma (March 8, 2009)

Advances in the Treatment of Low-grade Non-Hodgkin’s Lymphoma Recent advances in the treatment of low-grade non-Hodgkin’s lymphoma (NHL) have led to improvements in progression-free and overall survival. Research presented at the 2008 ASH... Continue Reading

Treanda® Less Toxic than CHOP Chemotherapy for Non-Hodgkin’s Lymphoma (March 8, 2009)

Treanda® Less Toxic than CHOP Chemotherapy for Non-Hodgkin’s Lymphoma According to the results of a study presented at the 50th annual meeting of the American Society of Hematology, initial treatment of non-Hodgkin’s lymphoma with Treanda®... Continue Reading

More Indolent/Low Grade Non-Hodgkin's Lymphoma

Inflammatory Breast Cancer

Racial Disparity in Breast Cancer Outcomes Among Underinsured (June 30, 2010)

Tykerb plus Taxol Is Active in Inflammatory Breast Cancer (June 17, 2010)

Tykerb® (lapatinib) plus Taxol® (paclitaxel) appears to provide benefit in the initial treatment of inflammatory breast cancer, according to results published in the Journal of Clinical Oncology. Inflammatory breast cancer (IBC) is the most aggressive... Continue Reading

Lifestyle Factors Increase Risk of Second Breast Cancer (September 24, 2009)

FDA Approves New Test to Detect HER2 Status in Breast Cancer (March 8, 2009)

FDA Approves New Test to Detect HER2 Status in Breast Cancer The U.S. Food and Drug Administration (FDA) has approved a new laboratory test to help identify patients with breast cancer who may benefit from treatment with Herceptin® (trastuzumab). The... Continue Reading

Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer (March 8, 2009)

Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published... Continue Reading

More Inflammatory Breast Cancer

Info Type

Sorry, there are no articles available for this cancer stage.

More Info Type

Sorry, there are no articles available for this cancer stage.

More J

Sorry, there are no articles available for this cancer stage.

More K

Sorry, there are no articles available for this cancer stage.

More L

Leukemia

Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients May Benefit from Sprycel/Chemotherapy Combination (July 28, 2010)

Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)

Mylotarg Withdrawn from Market in United States (June 23, 2010)

Tasigna Approved for Initial Treatment of Chronic Myeloid Leukemia (June 22, 2010)

Sprycel May Be More Effective than Gleevec for Initial Treatment of CML (June 7, 2010)

More Leukemia

Limited Disease Lung Cancer - Small Cell

November Is National Lung Cancer Awareness Month (November 6, 2009)

Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer (July 22, 2009)

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (March 8, 2009)

More Limited Disease Lung Cancer - Small Cell

Liver Cancer

Liver Cancer Incidence is on the Rise in the United States (May 25, 2010)

From 2001 to 2006, the incidence of hepatocellular carcinoma (HCC) increased significantly with an average increase of 3.5% annually. This analysis was recently reported in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality... Continue Reading

Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)

Incidence of Liver Cancer on the Rise (April 8, 2009)

The incidence of liver cancer in the United States tripled between 1975 and 2005, but survival rates are improving, according to the results of a study published in the Journal of Clinical Oncology. The liver is the largest organ in the body and is responsible... Continue Reading

More Liver Cancer

Locally Advanced Stage III (C) Prostate Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Study Explores Prostate Cancer Among Men with Low PSA Levels (July 30, 2010)

Addition of Radiation to Hormone Therapy Improves Survival in Locally Advanced Prostate Cancer (June 8, 2010)

The addition of radiation therapy to hormone therapy reduces the risk of prostate cancer death by 43% among men with locally advanced or high-risk prostate cancer compared with hormone therapy alone, according to the results of a phase III study presented... Continue Reading

Addition of Androgen Deprivation Therapy Improves Survival with Locally Advanced Prostate Cancer (October 8, 2009)

In men with locally advanced prostate cancer, the addition of androgen deprivation therapy to radiation therapy improves overall and progression-free survival without substantially affecting cardiovascular mortality. These results, based on close to 10... Continue Reading

Hormone Therapy in Prostate Cancer Increases Risk of Heart Disease (October 6, 2009)

Hormone therapy used to treat men with advanced prostate cancer may lead to an increased risk of heart disease, according to the results of a study presented on September 22, 2009 at Europe’s largest cancer congress, ECCO 15-ESMO 34, in Berlin.[1] Prostate... Continue Reading

More Locally Advanced Stage III (C) Prostate Cancer

Lung Cancer

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

Among postmenopausal women, hormone therapy with estrogen alone does not appear to increase the risk of getting or dying from lung cancer. These results were published in the Journal of the National Cancer Institute. As women reach menopause and beyond,... Continue Reading

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)

Anti-estrogens May Reduce Risk of Lung Cancer Death (December 14, 2009)

Sterotactic Radiosurgery Alone Is Preferred Treatment for Newly Diagnosed Brain Metastases (December 9, 2009)

More Lung Cancer

Lung Cancer - Non-Small Cell

Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)

Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer... Continue Reading

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)

A large Phase IV study confirms that the safety and efficacy reported in Phase III trials of Avastin® (bevacizumab) plus standard chemotherapy for patients with advanced non-squamous non-small cell lung cancer translate into the clinical practice setting.... Continue Reading

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)

The combination of vandetanib plus Taxotere resulted in longer survival without cancer progression than Taxotere alone among patients with previously-treated non–small cell lung cancer (NSCLC). These findings were recently published in the journal The... Continue Reading

More Lung Cancer - Non-Small Cell

Lung Cancer - Small Cell

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

High Rate of False-positive Results in Lung Cancer Screening with CT Scan (April 29, 2010)

Screening for lung cancer using computed tomography (CT) scans can yield a high rate of false-positive results, according to a study published in the Annals of Internal Medicine. False-positive results are risky because they may lead to invasive follow-up... Continue Reading

More Lung Cancer - Small Cell

Lymphoma

Intensive Chemotherapy Prolongs Remission of Mantle Cell Lymphoma (December 12, 2008)

Intensive Chemotherapy Prolongs Remission of Mantle Cell Lymphoma In a study of intensive chemotherapy for mantle cell lymphoma, more than half of patients 65 or younger were still in remission after seven years. These results were presented at the 50th... Continue Reading

More Lymphoma

Sorry, there are no articles available for this cancer stage.

More M

Management and Prevention of Anemia Supportive Care

Exercise Reduces Chemotherapy-related Fatigue (October 21, 2009)

Exercise reduces fatigue and improves strength, physical functioning, and emotional well-being in men and women undergoing chemotherapy, according to the results of a study published in the British Medical Journal.[1] While exercise has long been associated... Continue Reading

More Management and Prevention of Anemia Supportive Care

Management and Prevention of Anorexia and Weight Loss Supportive Care

Sorry, there are no articles available for this cancer stage.

More Management and Prevention of Anorexia and Weight Loss Supportive Care

Management and Prevention of Bone Complications Supportive Care

Bisphosphonates May Provide Breast Cancer Benefits (December 11, 2009)

Studies presented at the 2009 San Antonio Breast Cancer Symposium suggest that the class of bone drugs known as bisphosphonates may reduce the risk of breast cancer and may help to maintain bone density in breast cancer patients treated with aromatase... Continue Reading

Denosumab Reduces Bone Complications in Breast Cancer Patients with Bone Metastases (December 10, 2009)

Among women with bone metastases from breast cancer, the investigational drug denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase III clinical trial were... Continue Reading

Denosumab Provides Bone Benefits in Advanced Cancer (September 21, 2009)

Among patients with bone metastases from cancers other than breast or prostate cancer, denosumab is at least as effective as Zometa® (zoledronic acid) at reducing the risk of bone complications. These results were presented at a major European cancer... Continue Reading

Denosumab Reduces Fractures in Postmenopausal Osteoporosis (August 12, 2009)

Denosumab increases bone mineral density (BMD) and reduces the risk of vertebral fractures in women with postmenopausal osteoporosis, according to the results of a study published in the New England Journal of Medicine.[i] Denosumab is an investigational... Continue Reading

Denosumab Reduces Fractures in Non-metastatic Prostate Cancer (August 11, 2009)

Men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer experienced a 62% reduction in risk of vertebral fractures when treated with denosumab compared to men treated with placebo, according to the results of a study published... Continue Reading

More Management and Prevention of Bone Complications Supportive Care

Management and Prevention of Fatigue Supportive Care

Yoga Improves Sleep and Quality of Life (May 26, 2010)

A four-week yoga program that included breathing, meditation, postures, and other techniques improved sleep and quality of life among cancer survivors. The results of this study will be presented at the 2010 annual meeting of the American Society of Clinical... Continue Reading

More Management and Prevention of Fatigue Supportive Care

Management and Prevention of Mucositis Supportive Care

Oral Spray Reduces Mouth Sores (July 21, 2009)

Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published in Cancer. Mouth sores are one of the most... Continue Reading

More Management and Prevention of Mucositis Supportive Care

Management and Prevention of Neutropenia Supportive Care

Celebrities Stand Up to Cancer (September 14, 2009)

Celebrities and Amgen are joining forces to Stand Up to Cancer™—in the form of a public service campaign designed to educate cancer patients and caregivers about managing the increased risk of infection during cancer treatment. Chemotherapy is an... Continue Reading

Amgen Helps Reduce Out-of-pocket Costs for Neulasta® (July 3, 2009)

Amgen’s Neulasta FIRST STEP™ Program provides assistance to eligible, low-income, commercially-insured chemotherapy patients who need help with their co-insurance or co-payment requirement for Neulasta® (pegfilgrastim). Neulasta is a blood cell growth... Continue Reading

More Management and Prevention of Neutropenia Supportive Care

Management and Prevention of Thrombocytopenia Supportive Care

Nplate Evaluated in Children with Chronic ITP (December 9, 2009)

Among children with chronic immune thrombocytopenic purpura (ITP; an autoimmune disorder characterized by low platelet counts), treatment with Nplate® (romiplostim) stimulates platelet production and appears to be well tolerated. These results were presented... Continue Reading

More Management and Prevention of Thrombocytopenia Supportive Care

Mantle Cell Non-Hodgkin's Lymphoma

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (March 8, 2009)

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress (March 8, 2009)

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia (March 8, 2009)

More Mantle Cell Non-Hodgkin's Lymphoma

Melanoma

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Study Evaluates Melanoma Trends in High-risk Region of United States (July 27, 2010)

Melanoma incidence in Hispanic men and African-American women residing in Florida may be higher than in other regions of the United States. These findings were recently published in the journal Archives of Dermatology.[1] Many cases of melanoma are thought... Continue Reading

Ipilimumab Improves Outcomes in Advanced Melanoma (June 7, 2010)

Among patients with previously treated, advanced melanoma, treatment with the investigational drug ipilimumab improved overall and progression-free survival. The results of this Phase III clinical trial were presented at the 2010 annual meeting of the... Continue Reading

Indoor Tanning May Be Addictive in Some Individuals (April 30, 2010)

Hispanics and African Americans Present with More Advanced Melanoma than Whites (December 31, 2009)

Researchers from Florida have reported that Hispanics and African Americans present with more advanced melanomas than their White counterparts. These results were published in the Archives of Dermatology. The three most common types of skin cancer are... Continue Reading

More Melanoma

Mesothelioma

MVP Does Not Provide Benefit in Mesothelioma Patients (May 21, 2008)

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (February 8, 2008)

More Mesothelioma

Metastatic Breast Cancer

FDA Advisory Committee Recommends that Avastin No Longer Be Approved for Breast Cancer (July 29, 2010)

The Oncology Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) has voted 12 to one that Avastin® (bevacizumab) in combination with paclitaxel should no longer be approved for initial therapy for metastatic HER2-negative... Continue Reading

Olaparib Active Against Advanced Ovarian Cancer and Breast Cancer with BRCA Mutations (July 20, 2010)

Previously treated advanced breast and ovarian cancer patients with BRCA1 or BRCA2 gene mutation may benefit from treatment with the oral investigational drug olaparib. These findings were recently published in the journal The Lancet.[1],[2] Although... Continue Reading

Metastases from Breast Cancer May Differ from Primary Tumor (June 9, 2010)

It appears that in metastatic breast cancer, the biologic characteristics of liver metastases sometimes differ from those of the primary tumor. This finding may affect treatment choices for metastases. Results of this retrospective study were presented... Continue Reading

Herceptin plus Epirubicin and Cyclophosphamide Tolerable and Effective for HER2-positive Metastatic Breast Cancer (March 31, 2010)

For women with metastatic, HER2-positive breast cancer, the combination of Herceptin® (trastuzumab) with epirubicin and cyclophosphamide appears to offer a promising treatment option with a relatively low rate of heart complications. These results... Continue Reading

Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer (December 16, 2009)

According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented... Continue Reading

More Metastatic Breast Cancer

Metastatic Stage IV (D) Prostate Cancer

Provenge® for Hormone-refractory Prostate Cancer (August 11, 2010)

Among men with metastatic, hormone-refractory prostate cancer, the immunotherapy agent Provenge® (sipuleucel-T) improves survival by roughly four months. The findings from this Phase III study were recently published in The New England Journal of Medicine.[1] The... Continue Reading

Study Explores Prostate Cancer Among Men with Low PSA Levels (July 30, 2010)

Denosumab More Effective Than Zometa in Prostate Cancer Patients with Bone Metastases (June 7, 2010)

Among men with bone metastases from prostate cancer, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from this Phase III clinical trial will be presented at the 2010 annual... Continue Reading

Addition of Androgen Deprivation Therapy Improves Survival with Locally Advanced Prostate Cancer (October 8, 2009)

Hormone Therapy in Prostate Cancer Increases Risk of Heart Disease (October 6, 2009)

More Metastatic Stage IV (D) Prostate Cancer

Metastatic/Stage IVB Cervical Cancer

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

More Metastatic/Stage IVB Cervical Cancer

Miscellaneous

Sorry, there are no articles available for this cancer stage.

More Miscellaneous

Multiple Myeloma

Velcade® Improves Response Rate After High-dose Melphalan for Myeloma (December 21, 2009)

Among patients who have received high-dose melphalan and an autologous stem cell transplant for initial treatment of multiple myeloma, Velcade® (bortezomib) appears to improve treatment response rates. These results were presented at the 2009 meeting... Continue Reading

Revlimid® Delays Progression of Multiple Myeloma (December 18, 2009)

Among multiple myeloma patients who have had an autologous stem cell transplant, additional treatment with Revlimid® (lenalidomide) delays cancer progression. These results were released by the National Cancer Institute. Multiple myeloma is a cancer... Continue Reading

Pesticides Linked to Precancerous Blood Disorder (June 24, 2009)

Pesticides Linked to Precancerous Blood Disorder Individuals who apply pesticides to crops are twice as likely as the general population to develop a precancerous blood disorder called MGUS (monoclonal gammopathy of undetermined significance), which can... Continue Reading

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)

Thalomid® – Prolongs Survival in Multiple Myeloma (April 27, 2009)

One year of treatment with Thalomid® (thalidomide) and prednisone after a single autologous stem cell transplant prolongs survival in patients with newly diagnosed multiple myeloma, according to the results of a study published in the Journal of Clinical... Continue Reading

More Multiple Myeloma

Myelodysplastic Syndrome

Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes (March 6, 2009)

The American Society of Clinical Oncology 2008: Highlights of Treatment of Hematological Malignancies (January 30, 2009)

New Risk Model for MDS Applies to All Stages of Disease (December 31, 2008)

Older Age Does Not Affect Survival in Patients with AML or MDS Who Undergo Mini-transplants (December 30, 2008)

Vidaza® Approved for High-risk MDS (August 22, 2008)

More Myelodysplastic Syndrome

Sorry, there are no articles available for this cancer stage.

More N

Neuroblastoma

Immunotherapy Improves Outcomes for Patients with High-risk Neuroblastoma (May 21, 2009)

According to the results of a Phase III clinical trial that will be presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), use of an investigational immunotherapy treatment reduced the risk of relapse and improved survival... Continue Reading

More Neuroblastoma

News

Alcohol Linked with Lobular Breast Cancer (September 3, 2010)

Rectal Cancer Increasing in People Under 40 (September 2, 2010)

Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer. Colorectal cancer is the second leading cause of cancer death in the United... Continue Reading

Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)

Istodax Active against Refractory Cutaneous T-cell Lymphoma (August 31, 2010)

Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal of Clinical Oncology. Cutaneous T-cell lymphoma (CTCL)... Continue Reading

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

More News

Non-Hodgkin's Lymphoma

Istodax Active against Refractory Cutaneous T-cell Lymphoma (August 31, 2010)

Hepatitis B Virus Linked with Non-Hodgkin’s Lymphoma (August 17, 2010)

Individuals with chronic hepatitis B virus (HBV) infection may have an increased risk of developing non-Hodgkin’s lymphoma (NHL), according to findings recently published in The Lancet Oncology. Hepatitis B is a virus that causes inflammation of the... Continue Reading

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Maintenance Therapy with Rituxan Prolongs Lymphoma Remission (May 26, 2010)

Ontak Delays Progression of Patients with Cutaneous T-cell Lymphoma (March 31, 2010)

Among patients with cutaneous T-cell lymphoma, treatment with the drug Ontak® (denileukin diftitox) slows disease progression. These results were reported in the Journal of Clinical Oncology. T-cell lymphoma, a type of non-Hodgkin’s lymphoma,... Continue Reading

More Non-Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More O

Osteosarcoma

Sorry, there are no articles available for this cancer stage.

More Osteosarcoma

Other News Topics (not Types of Cancer)

Childhood Cancer Survivors Treated with Radiation Therapy at Increased Risk of Death from Heart Disease in Adulthood (March 26, 2010)

Marital Separation Impacts Cancer Survival (September 17, 2009)

Individuals who are separated from their spouse at the time of their cancer diagnosis have a lower survival rate than other unmarried patients (including never married, divorced, widowed), according to the results of a study published in Cancer.[1] Past... Continue Reading

More Other News Topics (not Types of Cancer)

Ovarian Cancer

Continued Chemotherapy in Advanced Ovarian Cancer (August 9, 2010)

Continuing chemotherapy following initial treatment of advanced ovarian cancer may improve survival, according to a study published in Cancer. Ovarian cancer has the highest mortality rate of all gynecologic cancers. It is the fifth leading cause of cancer... Continue Reading

Olaparib Active Against Advanced Ovarian Cancer and Breast Cancer with BRCA Mutations (July 20, 2010)

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Combination of Trabectedin and Pegylated Liposomal Doxorubicin Modestly Delays Progression of Recurrent Ovarian Cancer (July 9, 2010)

The combination of the investigational agent trabectedin with pegylated liposomal doxorubicin (PLD) resulted in a 1.5-month improvement in progression-free survival in women with recurrent ovarian cancer. Final information about overall survival is not... Continue Reading

Olaparib Shows Promise in High-grade Serous Ovarian Cancer (June 16, 2010)

Advanced serous ovarian cancer responds to single-agent treatment with olaparib, according to the results of a Phase II study presented at the 2010 annual meeting of the American Society of Clinical Oncology.[1] Ovarian cancer has the highest mortality... Continue Reading

More Ovarian Cancer

Sorry, there are no articles available for this cancer stage.

More P

Pain Management Supportive Care

Acupuncture Relieves Pain, Improves Functioning After Neck Surgery (April 29, 2010)

Acupuncture may reduce pain and improve functioning among patients with cancer who have undergone surgery to the neck, according to a study published in the Journal of Clinical Oncology.[1] As well, acupuncture may relieve xerostomia (dry mouth) among... Continue Reading

Onsolis Approved for Breakthrough Pain (July 28, 2009)

Onsolis (fentanyl buccal soluble film) has been approved by the U.S. Food and Drug Administration for the treatment of breakthrough cancer pain.[1] Pain may be a side effect of cancer treatment or may be caused by the cancer itself. If not adequately... Continue Reading

More Pain Management Supportive Care

Pancreatic Cancer

Gemzar plus Avastin Does Not Improve Survival in Advanced Pancreatic Cancer (July 14, 2010)

Results from a recent Phase III trial indicate that the addition of the targeted therapy Avastin® (bevacizumab) to the chemotherapy drug Gemzar® (gemcitabine) does not improve survival in advanced pancreatic cancer. These findings were reported in the... Continue Reading

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Afinitor Delays Progression of Advanced Pancreatic Neuroendocrine Tumors (July 8, 2010)

In a recent Phase III trial, the targeted therapy Afinitor® (everolimus) more than doubled progression-free survival time among patients with advanced pancreatic neuroendocrine tumors (NET). Results of this study were presented at the 12th World Congress... Continue Reading

Improved Survival in Metastatic Pancreatic Cancer (June 24, 2010)

It appears that the chemotherapy combination known as FOLFIRINOX may improve survival in metastatic pancreatic cancer over a current standard-of-care, Gemzar® (gemcitabine). The results of this Phase III study were presented at the 2010 annual meeting... Continue Reading

AMG 479 Produces Promising Results in Metastatic Pancreatic Cancer (June 7, 2010)

According to the results of a Phase II clinical trial, treatment of metastatic pancreatic cancer with a combination of AMG 479 and Gemzar® (gemcitabine) resulted in better progression-free and overall survival than treatment with Gemzar alone. These... Continue Reading

More Pancreatic Cancer

Progressive Relapsed Hodgkin's Lymphoma

Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (September 24, 2009)

Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)

Autologous Stem Cell Transplantation Effective for Relapsed Hodgkin’s Lymphoma (March 8, 2009)

Autologous Stem Cell Transplantation Effective for Relapsed Hodgkin’s Lymphoma Autologous stem cell transplantation is effective for patients with Hodgkin’s lymphoma that has progressed following prior therapies. These results were recently... Continue Reading

More Progressive Relapsed Hodgkin's Lymphoma

Prostate Cancer

Death from Other Causes Among Men with Early-stage Prostate Cancer (August 26, 2010)

Study Evaluates Physician Use of Finasteride for Prostate Cancer Prevention (August 18, 2010)

Recent research indicates that 64% of urologists and 80% of primary care physicians surveyed do not prescribe finasteride for prevention of prostate cancer in high-risk men. These findings were recently published in the journal Cancer Epidemiology, Biomarkers... Continue Reading

Provenge® for Hormone-refractory Prostate Cancer (August 11, 2010)

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Study Explores Prostate Cancer Among Men with Low PSA Levels (July 30, 2010)

More Prostate Cancer

Sorry, there are no articles available for this cancer stage.

More Q

Sorry, there are no articles available for this cancer stage.

More R

Radiopharmaceutical

Sorry, there are no articles available for this cancer stage.

More Radiopharmaceutical

Rectal Cancer

Rectal Cancer Increasing in People Under 40 (September 2, 2010)

Pathological Complete Response Predicts Better Outcomes in Locally Advanced Rectal Cancer Patients (August 25, 2010)

Among patients with locally advanced rectal cancer, a complete disappearance of detectable cancer (pathological complete response) after preoperative chemoradiation therapy is linked with better long-term outcomes. These findings were recently published... Continue Reading

Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)

Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

More Rectal Cancer

Recurrent Anal Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Anal Cancer

Recurrent Breast Cancer

Olaparib Active Against Advanced Ovarian Cancer and Breast Cancer with BRCA Mutations (July 20, 2010)

Racial Disparity in Breast Cancer Outcomes Among Underinsured (June 30, 2010)

Eribulin Improves Survival with Metastatic Breast Cancer (June 8, 2010)

Among women with previously treated, locally recurrent or metastatic breast cancer, treatment with the investigational chemotherapy drug eribulin mesylate improved overall survival by about 2.5 months. The results of this Phase III clinical trial were... Continue Reading

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer (December 16, 2009)

More Recurrent Breast Cancer

Recurrent Cervical Cancer

Avastin® Shows Promise in Treatment of Cervical Cancer (March 8, 2009)

Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 8, 2009)

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective... Continue Reading

More Recurrent Cervical Cancer

Recurrent Gastric Cancer

Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)

Herceptin® Improves Survival with HER2-positive Gastric Cancer (June 2, 2009)

Herceptin® Improves Survival with HER2-positive Gastric Cancer According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy... Continue Reading

More Recurrent Gastric Cancer

Recurrent Liver Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Liver Cancer

Recurrent Lung Cancer - Non-Small Cell

Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)

Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)

November Is National Lung Cancer Awareness Month (November 6, 2009)

Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer (March 8, 2009)

Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer According to the results of a Phase III clinical trial, treatment with Avastin® (bevacizumab) plus Tarceva® (erlotinib) did... Continue Reading

Nexavar® Improves Survival in Recurrent Non–Small Cell Lung Cancer (March 8, 2009)

Nexavar® Improves Survival in Recurrent Non–Small Cell Lung Cancer Patients with recurrent non–small cell lung cancer (NSCLC) who were treated with Nexavar® (sorafenib) experienced a delay in disease progression and a possible improvement in overall... Continue Reading

More Recurrent Lung Cancer - Non-Small Cell

Recurrent Lung Cancer - Small Cell

November Is National Lung Cancer Awareness Month (November 6, 2009)

More Recurrent Lung Cancer - Small Cell

Recurrent Melanoma

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates (March 8, 2009)

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates Patients who undergo preventive dental care prior to receiving therapy with bisphosphonates have a significantly reduced risk of developing osteonecrosis of the jaw.... Continue Reading

More Recurrent Melanoma

Recurrent Multiple Myeloma

Velcade® plus Perifosine Shows Promise in Relapsed or Refractory Multiple Myeloma (March 8, 2009)

Velcade® plus Perifosine Shows Promise in Relapsed or Refractory Multiple Myeloma Among patients with relapsed or refractory multiple myeloma previously treated with Velcade® (bortezomib), 40% responded to treatment with a combination of Velcade and... Continue Reading

Multiple Myeloma Treatment Does Not Affect the Outcome of Stem Cell Transplant (March 8, 2009)

Multiple Myeloma Treatment Does Not Affect the Outcome of Stem Cell Transplant A recently published study indicates that the type of initial chemotherapy for multiple myeloma has no impact on the outcome of patients who later undergo autologous stem cell... Continue Reading

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates (March 8, 2009)

More Recurrent Multiple Myeloma

Recurrent Non-Hodgkin's Lymphoma

Veltuzumab Effective for Refractory Non-Hodgkin’s Lymphoma (July 29, 2009)

Veltuzumab is safe and effective for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma, according to the results of a study published in the Journal of Clinical Oncology.[1] Non-Hodgkin’s lymphoma (NHL) is a form of cancer that begins... Continue Reading

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (March 8, 2009)

Zevalin® Effective for Patients with Follicular Lymphoma Following an Autologous Transplant (March 8, 2009)

Zevalin® Effective for Patients with Follicular Lymphoma Following an Autologous Transplant Zevalin® (Yttrium-90 [(90)Y] ibritumomab tiuxetan) appears to provide effective, long-term anticancer responses for patients with follicular lymphoma whose cancer... Continue Reading

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma (March 8, 2009)

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (March 8, 2009)

More Recurrent Non-Hodgkin's Lymphoma

Recurrent Ovarian Cancer

Olaparib Active Against Advanced Ovarian Cancer and Breast Cancer with BRCA Mutations (July 20, 2010)

Combination of Trabectedin and Pegylated Liposomal Doxorubicin Modestly Delays Progression of Recurrent Ovarian Cancer (July 9, 2010)

Farletuzumab Shows Promise in Relapsed Ovarian Cancer (October 7, 2009)

According to the results of a Phase II clinical trial, the investigational drug farletuzumab may have anticancer activity in the treatment of relapsed ovarian cancer when combined with chemotherapy. These results were presented at a European cancer conference. Many... Continue Reading

September Is National Ovarian Cancer Awareness Month (September 1, 2009)

As the month of September brings ovarian cancer into focus, it’s time to increase public understanding about the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer... Continue Reading

Initiating Treatment Due to Elevated CA125 Marker Does Not Improve Survival in Recurrent Ovarian Cancer (June 2, 2009)

Initiating Treatment Due to Elevated CA125 Marker Does Not Improve Survival in Recurrent Ovarian Cancer Early treatment for recurrent ovarian cancer based on a rising CA125 marker does not appear to improve overall survival compared with treatment that... Continue Reading

More Recurrent Ovarian Cancer

Recurrent Pancreatic Cancer

November Is National Pancreatic Cancer Awareness Month (November 5, 2009)

As the month of November brings pancreatic cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated pancreatic... Continue Reading

More Recurrent Pancreatic Cancer

Recurrent Testicular Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Testicular Cancer

Recurrent Uterine Cancer

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 8, 2009)

More Recurrent Uterine Cancer

Recurrent/Relapsed Rectal Cancer

Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)

Vectibix Improves Outcome of Previously Treated Colorectal Cancer (January 27, 2010)

Among patients with previously treated, metastatic colorectal cancer, the addition of the targeted therapy Vectibix® (panitumumab) to chemotherapy delayed cancer progression. This benefit was only observed in patients whose tumors did not contain... Continue Reading

Hemoglobin Level Among Factors that May Predict Outcome in Rectal Cancer (March 8, 2009)

Hemoglobin Level Among Factors that May Predict Outcome in Rectal Cancer Researchers in the United States have recently published results indicating that certain prognostic factors may predict outcome for patients undergoing radiation for locally recurrent... Continue Reading

Early Skin Treatment Reduces Skin Reactions in Colorectal Cancer Patients Treated with Vectibix® (March 8, 2009)

Early Skin Treatment Reduces Skin Reactions in Colorectal Cancer Patients Treated with Vectibix® Among patients with colorectal cancer, skin treatment beginning on the day prior to therapy with Vectibix® (panitumumab) significantly reduces skin side... Continue Reading

Testing for Specific Protein May Identify Colorectal Patients Who Will Benefit from Erbitux® (March 8, 2009)

Testing for Specific Protein May Identify Colorectal Patients Who Will Benefit from Erbitux® Researchers have identified a test to predict which patients with colorectal cancer would likely respond to treatment with Erbitux® (cetuximab). Details of... Continue Reading

More Recurrent/Relapsed Rectal Cancer

Refactory/Recurrent Prostate Cancer

Jevtana Approved for Hormone-refractory Prostate Cancer (June 21, 2010)

Jevtana® (cabazitaxel), a new chemotherapy drug, was approved for use in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer previously treated with a Taxotere® (docetaxel)-containing regimen. Prostate... Continue Reading

Denosumab More Effective Than Zometa in Prostate Cancer Patients with Bone Metastases (June 7, 2010)

Provenge Approved for Advanced Prostate Cancer (May 1, 2010)

Provenge® (sipuleucel-T), a type of immunotherapy, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of asymptomatic or minimally symptomatic, metastatic, hormone-refractory prostate cancer.[1] Prostate cancer is... Continue Reading

Investigational Drug Shows Activity in Advanced Prostate Cancer (April 26, 2010)

An investigational anti-androgen drug called MDV3100 has shown encouraging anti-tumor activity in patients with progressive, metastatic, hormone-resistant prostate cancer, according to the preliminary results of a study published early online in the... Continue Reading

September Is National Prostate Cancer Awareness Month (August 31, 2009)

As the month of September brings prostate cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer... Continue Reading

More Refactory/Recurrent Prostate Cancer

Renal Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

Some Chinese Herbs May Increase Risk of Urinary Tract Cancer (February 18, 2010)

Votrient Improves Progression-free Survival in Advanced Kidney Cancer (January 27, 2010)

Sterotactic Radiosurgery Alone Is Preferred Treatment for Newly Diagnosed Brain Metastases (December 9, 2009)

More Renal Cancer

Retinoblastoma

Long-term Retinoblastoma Survivors at Greater Risk of Dying from Subsequent Cancers (May 11, 2009)

Long-term retinoblastoma survivors are at a greater risk of dying from subsequent cancers and this elevated risk extends beyond 40 years, according to the results of a study published in the Journal of the National Cancer Institute.1 Retinoblastoma... Continue Reading

More Retinoblastoma

Sorry, there are no articles available for this cancer stage.

Sarcoma

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Study Evaluates Anthracycline-related Heart Problems in Childhood Cancer Survivors (May 28, 2010)

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

Targeted Heat Therapy Improves Outcomes for Soft Tissue Sarcoma (September 30, 2009)

More Sarcoma

Screening/Prevention Anal Cancer

Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)

More Screening/Prevention Anal Cancer

Screening/Prevention Bladder Cancer

Components of Processed Meat May Increase Risk of Bladder Cancer (August 10, 2010)

Painters May Have Higher Risk of Bladder Cancer (July 29, 2010)

Exposure to Aromatic Amines Poses Long-term Risk of Bladder Cancer (June 25, 2010)

Vitamins C, D, and E Don’t Reduce Risk of Bladder Cancer (June 7, 2010)

Well-done Red Meat Increases Bladder Cancer Risk (April 27, 2010)

Some individuals are more genetically susceptible to this risk. High consumption of red meat and/or fried meats such as chicken or fish increase the risk of bladder cancer, especially among individuals who already carry a genetic risk, according to... Continue Reading

More Screening/Prevention Bladder Cancer

Screening/Prevention Breast Cancer

Alcohol Linked with Lobular Breast Cancer (September 3, 2010)

Additional Research on Menopausal Hormone Therapy and Breast Cancer (August 24, 2010)

Mediterranean Diet May Lower Breast Cancer Risk (August 16, 2010)

Breast Density and Hormone Therapy Add to Breast Cancer Risk (August 4, 2010)

Postmenopausal women with high breast density are at an increased risk of developing breast cancer, according to the results of a study published in the Journal of Clinical Oncology.[1] This risk increases with the use of hormone therapy. Breast density... Continue Reading

More Screening/Prevention Breast Cancer

Screening/Prevention Cervical Cancer

HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)

Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)

More Than Half of Young Adults in New Relationships Infected with HPV (April 26, 2010)

ACOG Updates Cervical Cancer Screening Guidelines (November 20, 2009)

Second HPV Vaccine Approved in U.S. (October 16, 2009)

The U.S. Food and Drug Administration has approved Cervarix®, a vaccine against two high-risk types of human papillomavirus (HPV), for prevention of cervical cancer and cervical precancers. This is the second HPV vaccine to be approved in the United... Continue Reading

More Screening/Prevention Cervical Cancer

Screening/Prevention Colon Cancer

Screening Rates Among Older Americans (July 15, 2010)

Early Morning Colonoscopies Detect More Polyps (November 11, 2009)

Among patients undergoing colonoscopy at a Veteran’s Administration (VA) medical center, a greater number of polyps was detected among patients seen early in the morning than among patients seen later in the day. The reasons for this are uncertain,... Continue Reading

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

Daily Aspirin Prevents Colorectal Cancer in Lynch Syndrome (October 5, 2009)

Daily aspirin may prevent the incidence of cancer in individuals who are genetically predisposed to hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch Syndrome, according to the results of a study presented September 21, 2009 at Europe’s... Continue Reading

False-positive Results Are Common with Cancer Screening (July 21, 2009)

The risk of obtaining a false-positive result from screening for prostate, lung, colorectal, and ovarian cancer is high and becomes cumulatively higher with ongoing screening—after 14 screening tests, the cumulative risk of a false-positive is 60.4%... Continue Reading

More Screening/Prevention Colon Cancer

Screening/Prevention Esophageal Cancer

Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer (August 23, 2010)

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

New Study Confirms Increased Incidence of Adenocarcinoma of the Esophagus in White Americans (March 8, 2009)

New Study Confirms Increased Incidence of Adenocarcinoma of the Esophagus in White Americans Researchers from the National Institutes of Health have reported that between 1975 and 2004, the incidence of adenocarcinoma of the esophagus increased by 463%... Continue Reading

Obesity and Acid Reflux Significantly Increase Risk of Developing Esophageal Cancer (March 8, 2009)

Obesity and Acid Reflux Significantly Increase Risk of Developing Esophageal Cancer According to an article recently published in the journal Gut, individuals who are obese and have frequent symptoms of acid reflux have a significantly increased risk... Continue Reading

More Screening/Prevention Esophageal Cancer

Screening/Prevention Gastric Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Aspirin May Reduce Risk of Stomach Cancer (August 28, 2009)

Regular aspirin use may reduce the risk of distal stomach cancer (cancer in the lower part of the stomach). These results were published in the American Journal of Epidemiology. Cancer of the stomach is called gastric cancer. Gastric adenocarcinoma is... Continue Reading

Fruits and Vegetables Reduce Risk of Stomach Cancer (March 8, 2009)

Fruits and Vegetables Reduce Risk of Stomach Cancer According to an article recently published in the American Journal of Epidemiology, diets higher in vegetables and fruits and lower in foods common in Western diets (such as processed meats, soft drinks,... Continue Reading

More Screening/Prevention Gastric Cancer

Screening/Prevention Leukemia

Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)

Cyclophosphamide May Increase Cancer Risk Among Patients with Rheumatoid Arthritis (March 8, 2009)

Cyclophosphamide May Increase Cancer Risk Among Patients with Rheumatoid Arthritis A large study conducted in Canada reveals that patients who are treated for rheumatoid arthritis (RA) with the drug cyclophosphamide may have an increased risk for developing... Continue Reading

Being Overweight Associated with Increased Risk of Several Cancers (March 8, 2009)

Being Overweight Associated with Increased Risk of Several Cancers Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet. It is estimated that in the United States, one out of... Continue Reading

More Screening/Prevention Leukemia

Screening/Prevention Liver Cancer

Liver Cancer Incidence is on the Rise in the United States (May 25, 2010)

Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (March 8, 2009)

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (March 8, 2009)

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF (March 8, 2009)

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF According to an article recently published in the Journal of the American Medical Association, patients with cirrhosis of the liver who overexpress epithelial growth factor... Continue Reading

More Screening/Prevention Liver Cancer

Screening/Prevention Lung Cancer - Non-Small Cell

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)

High Rate of False-positive Results in Lung Cancer Screening with CT Scan (April 29, 2010)

November Is National Lung Cancer Awareness Month (November 6, 2009)

More Screening/Prevention Lung Cancer - Non-Small Cell

Screening/Prevention Lung Cancer - Small Cell

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)

Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)

Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)

High Rate of False-positive Results in Lung Cancer Screening with CT Scan (April 29, 2010)

November Is National Lung Cancer Awareness Month (November 6, 2009)

More Screening/Prevention Lung Cancer - Small Cell

Screening/Prevention Melanoma

Study Evaluates Melanoma Trends in High-risk Region of United States (July 27, 2010)

Indoor Tanning May Be Addictive in Some Individuals (April 30, 2010)

Hispanics and African Americans Present with More Advanced Melanoma than Whites (December 31, 2009)

Dermatologists Detect Thinner Melanomas (October 5, 2009)

In a study conducted at a private dermatology practice, a majority of melanomas were identified as a result of a full-body skin exam and not as a result of a patient complaint. Furthermore, melanomas detected by the dermatologist tended to be thinner... Continue Reading

Tanning Beds Classified as “Carcinogenic to Humans” (July 30, 2009)

More Screening/Prevention Melanoma

Screening/Prevention Non-Hodgkin's Lymphoma

Hepatitis B Virus Linked with Non-Hodgkin’s Lymphoma (August 17, 2010)

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Number of Obesity-related Cancers Is Growing (October 3, 2009)

In 2008, excess body weight was responsible for over 124,000 new cancer diagnoses in Europe. These results were presented at a major European cancer conference. Obesity is increasingly being recognized as a risk factor not only for cancer development,... Continue Reading

Cyclophosphamide May Increase Cancer Risk Among Patients with Rheumatoid Arthritis (March 8, 2009)

Being Overweight Associated with Increased Risk of Several Cancers (March 8, 2009)

More Screening/Prevention Non-Hodgkin's Lymphoma

Screening/Prevention Ovarian Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Regular Aspirin Use May Reduce Risk of Ovarian Cancer (February 18, 2010)

According to results from the Iowa Women’s Health Study, regular aspirin use may reduce the risk of developing ovarian cancer but does not appear to affect the risk of endometrial cancer. These results were published in Cancer Epidemiology, Biomarkers,... Continue Reading

Search for Early Markers of Ovarian Cancer Continues (January 20, 2010)

Levels of three potential biological markers of ovarian cancer—CA125, human epididymis protein 4, and mesothelin—begin to rise three years before the clinical diagnosis of ovarian cancer, but only become substantially elevated less than a year before... Continue Reading

Number of Obesity-related Cancers Is Growing (October 3, 2009)

Women Report Symptoms Prior to Diagnosis of Ovarian Cancer (September 2, 2009)

Women commonly report symptoms to their primary care provider during the year before a diagnosis of ovarian cancer. The results of this study, which was conducted in the UK, were published in the British Medical Journal. Ovarian cancer has the highest... Continue Reading

More Screening/Prevention Ovarian Cancer

Screening/Prevention Pancreatic Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

November Is National Pancreatic Cancer Awareness Month (November 5, 2009)

Lynch Syndrome Increases Risk of Pancreatic Cancer (November 2, 2009)

Lynch Syndrome, an inherited cause of colorectal cancer that also increases the risk of several other types of cancer, results in a risk of pancreatic cancer that is several times higher than the risk in the general population. These results were published... Continue Reading

Number of Obesity-related Cancers Is Growing (October 3, 2009)

More Screening/Prevention Pancreatic Cancer

Screening/Prevention Prostate Cancer

Study Evaluates Physician Use of Finasteride for Prostate Cancer Prevention (August 18, 2010)

Dogs May Be Able to Smell Prostate Cancer (June 8, 2010)

Dogs may be able to smell the presence of prostate cancer in patient urine samples, according to data presented at the 2010 Annual Scientific Meeting of the American Urological Association (AUA). Volatile organic compounds (VOCs) are organic chemical... Continue Reading

Coffee May Reduce Risk of Lethal and Advanced Prostate Cancer (December 18, 2009)

Men who drink coffee may have a reduced risk of developing lethal and advanced prostate cancer. These results were presented at the 2009 AACR Frontiers in Cancer Prevention Research conference. Prostate cancer is the most common cancer (other than skin... Continue Reading

Infection Linked with Aggressive Prostate Cancer (September 16, 2009)

The sexually transmitted infection Trichomonas vaginalis may increase the risk of advanced prostate cancer. These results were published in the Journal of the National Cancer Institute. Trichomonas vaginalis is a single-celled protozoan parasite. It is... Continue Reading

Study Explores Overdiagnosis of Prostate Cancer (September 10, 2009)

For every man who benefits from prostate cancer screening, many more are diagnosed and treated unnecessarily. The extent of this “overdiagnosis” of prostate cancer was explored in a study published in the Journal of the National Cancer Institute. Each... Continue Reading

More Screening/Prevention Prostate Cancer

Screening/Prevention Rectal Cancer

Rectal Cancer Increasing in People Under 40 (September 2, 2010)

Early Morning Colonoscopies Detect More Polyps (November 11, 2009)

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

Daily Aspirin Prevents Colorectal Cancer in Lynch Syndrome (October 5, 2009)

False-positive Results Are Common with Cancer Screening (July 21, 2009)

More Screening/Prevention Rectal Cancer

Screening/Prevention Uterine Cancer

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)

Regular Aspirin Use May Reduce Risk of Ovarian Cancer (February 18, 2010)

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

Coffee Consumption May Reduce Risk of Uterine Cancer (October 20, 2009)

Coffee consumption may reduce the incidence of uterine cancer, especially among overweight and obese women, according to the results of a study published in the International Journal of Cancer.[1] Researchers continue to evaluate the link between dietary... Continue Reading

Being Overweight Associated with Increased Risk of Several Cancers (March 8, 2009)

More Screening/Prevention Uterine Cancer

Skin Cancer

HPV Infection May Raise Skin Cancer Risk (July 13, 2010)

Indoor Tanning May Be Addictive in Some Individuals (April 30, 2010)

May Is National Skin Cancer Awareness Month (March 8, 2009)

May Is National Skin Cancer Awareness Month As the month of May brings skin cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

More Skin Cancer

Skin Cancer Overview

Sorry, there are no articles available for this cancer stage.

More Skin Cancer Overview

Soft Tissue Sarcomas

Sorry, there are no articles available for this cancer stage.

More Soft Tissue Sarcomas

Stage I Cervical Cancer

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer (June 9, 2009)

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

More Stage I Cervical Cancer

Stage I Node Negative Breast Cancer

Study Evaluates Impact of Lymph Node Removal in Early-stage Breast Cancer (August 13, 2010)

Updated Guidelines Address Hormonal Therapy for Breast Cancer (July 21, 2010)

Among postmenopausal women with hormone receptor-positive breast cancer, use of an aromatase inhibitor at some point in the course of adjuvant (post-surgery) treatment results in a lower risk of cancer recurrence than use of tamoxifen only. Based on these... Continue Reading

Many Breast Cancer Patients Taking Adjuvant Hormonal Therapy Stop Treatment Early (July 1, 2010)

Less than half of early-stage breast cancer patients with hormone-sensitive disease completed the full dose and schedule of their hormonal therapy treatment. These findings were recently published in the Journal of Clinical Oncology.[1] The majority of... Continue Reading

Racial Disparity in Breast Cancer Outcomes Among Underinsured (June 30, 2010)

Gene Mutation Increases Risk of Blood Clots in Breast Cancer Patients Taking Tamoxifen (June 29, 2010)

Among women taking tamoxifen for early-stage breast cancer, an inherited gene mutation (Factor V Leiden) may increase the risk of blood clots. These results, which differ from a previous study that evaluated women taking tamoxifen for breast cancer prevention,... Continue Reading

More Stage I Node Negative Breast Cancer

Stage I Ovarian Cancer

September Is National Ovarian Cancer Awareness Month (September 1, 2009)

Fertility Preservation Appears to Be Safe for Young Women with Early-stage Ovarian Cancer (August 11, 2009)

Preservation of the non-cancerous ovary and the uterus appears to be safe for young women with Stage IA or IC ovarian cancer and allows women to preserve their fertility. These results were published in Cancer. Women who confront a cancer diagnosis at... Continue Reading

Ovarian Cancer National Alliance Announces Eleventh Annual Conference (March 8, 2009)

Ovarian Cancer National Alliance Announces Eleventh Annual Conference This year the Ovarian Cancer National Alliance will hold their eleventh annual conference, titled “Creating Currents of Change,” on Tuesday, July 8 through Thursday, July... Continue Reading

Specialty Hospitals Associated with Improved Survival in Early Ovarian Cancer (March 8, 2009)

Specialty Hospitals Associated with Improved Survival in Early Ovarian Cancer Hospitals that specialize in care for ovarian cancer are associated with significantly improved survival for women with early ovarian cancer. These results were recently reported... Continue Reading

Further Evidence in Favor of Care for Ovarian Cancer Patients by Gynecologic Oncologists (March 8, 2009)

Further Evidence in Favor of Care for Ovarian Cancer Patients by Gynecologic Oncologists According to an article recently published in Gynecologic Oncology, patients under 55 years of age with Stages IC–II ovarian cancer were more likely to receive... Continue Reading

More Stage I Ovarian Cancer

Stage I-II Testicular Cancer

New Genes Linked to Testicular Cancer (June 28, 2010)

Scientists have discovered three new genes associated with testicular cancer, according to the results of a study published in Nature Genetics.[1] Testicular cancer is the most common type of cancer in men ages 15 to 45. The incidence of testicular cancer... Continue Reading

Men with Infertility May Have Increased Risk of Testicular Cancer (March 8, 2009)

Men with Infertility May Have Increased Risk of Testicular Cancer Men with infertility are three times more likely to develop testicular cancer compared with fertile men, according to the results of a study published in the Archives of Internal Medicine.[1] The... Continue Reading

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer (March 8, 2009)

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer Among men with Stage I seminoma (a type of testicular cancer), post-surgery treatment with a single dose of the chemotherapy drug carboplatin is as effective as two to... Continue Reading

More Stage I-II Testicular Cancer

Stage I/Smoldering Myeloma Multiple Myeloma

Velcade® Improves Response Rate After High-dose Melphalan for Myeloma (December 21, 2009)

Revlimid® Delays Progression of Multiple Myeloma (December 18, 2009)

Pesticides Linked to Precancerous Blood Disorder (June 24, 2009)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)

Velcade® Approved for Initial Therapy of Multiple Myeloma (March 8, 2009)

Velcade® Approved for Initial Therapy of Multiple Myeloma The United States Food and Drug Administration (FDA) has approved Velcade® (bortezomib) as initial therapy for the treatment of multiple myeloma. Velcade is already approved for the treatment... Continue Reading

More Stage I/Smoldering Myeloma Multiple Myeloma

Stage II-IV Ovarian Cancer

Continued Chemotherapy in Advanced Ovarian Cancer (August 9, 2010)

Olaparib Shows Promise in High-grade Serous Ovarian Cancer (June 16, 2010)

Avastin Delays Progression of Advanced Ovarian Cancer (June 8, 2010)

In a Phase III clinical trial, the addition of the targeted therapy Avastin® (bevacizumab) to chemotherapy, followed by maintenance therapy with Avastin, slowed cancer progression among women with advanced ovarian, primary peritoneal, or Fallopian tube... Continue Reading

Avastin May Delay Progression of Ovarian Cancer (February 26, 2010)

Among women with advanced ovarian cancer, treatment with a combination of Avastin® (bevacizumab) and chemotherapy, followed by maintenance treatment with Avastin, may result in better progression-free survival than chemotherapy alone. Initial results... Continue Reading

September Is National Ovarian Cancer Awareness Month (September 1, 2009)

More Stage II-IV Ovarian Cancer

Stage III Bladder Cancer

Sorry, there are no articles available for this cancer stage.

More Stage III Bladder Cancer

Stage III Melanoma

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Ipilimumab Improves Outcomes in Advanced Melanoma (June 7, 2010)

Adjuvant Radiation Therapy May Improve Melanoma Outcomes (October 5, 2009)

Adjuvant radiation therapy improves local control of melanoma following therapeutic lymph node dissection for lymph node-metastatic disease and may improve disease-specific survival, according to the results of a study published in Cancer.[1] Skin cancer... Continue Reading

Pegylated Interferon Alfa-2b Reduces Quality of Life in Stage III Melanoma (July 30, 2009)

Although it improves recurrence-free survival, adjuvant (post-surgery) treatment with pegylated interferon alfa-2b adversely affects quality of life among patients with Stage III melanoma. These results were published in the Journal of Clinical Oncology. Skin... Continue Reading

Experimental Vaccine Improves Melanoma Outcomes (June 5, 2009)

Experimental Vaccine Improves Melanoma Outcomes Patients with advanced melanoma experienced higher response rates and longer survival without cancer progression when treated with an experimental anticancer vaccine in addition to standard therapy. These... Continue Reading

More Stage III Melanoma

Stage III Testicular Cancer

New Genes Linked to Testicular Cancer (June 28, 2010)

More Stage III Testicular Cancer

Stage IV (D)/Relapsed Colon Cancer

Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

Vectibix Improves Outcome of Previously Treated Colorectal Cancer (January 27, 2010)

First-line Vectibix Delays Progression of Metastatic Colorectal Cancer (January 27, 2010)

Among patients with metastatic colorectal cancer that does not have a mutation in the KRAS gene, initial treatment with a combination of chemotherapy and Vectibix® (panitumumab) delays cancer progression by 1.6 months compared with chemotherapy alone.... Continue Reading

More Stage IV (D)/Relapsed Colon Cancer

Stage IV Anal Cancer

No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)

No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading

More Stage IV Anal Cancer

Stage IV Liver Cancer

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (March 8, 2009)

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and Tarceva® (erlotinib)-has anticancer activity in patients... Continue Reading

Nexavar® Effective for Hepatocellular Carcinoma in Asians (March 8, 2009)

Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular carcinoma (liver cancer). The results of this study were... Continue Reading

More Stage IV Liver Cancer

Stage IV Melanoma

Ipilimumab Improves Outcomes in Advanced Melanoma (June 7, 2010)

Some Patients with Previously Treated Melanoma Respond to Ipilimumab (December 22, 2009)

In a Phase II clinical trial, 11% of patients with previously treated, advanced melanoma experienced a complete or partial disappearance of detectable cancer following treatment with ipilimumab at a dose of 10 mg/kg. These results were published in Lancet... Continue Reading

Sterotactic Radiosurgery Alone Is Preferred Treatment for Newly Diagnosed Brain Metastases (December 9, 2009)

Experimental Vaccine Improves Melanoma Outcomes (June 5, 2009)

Paraplatin®, Taxol®, and Avastin® Beneficial for Metastatic Melanoma (March 8, 2009)

Paraplatin®, Taxol®, and Avastin® Beneficial for Metastatic Melanoma The combination of Paraplatin® (carboplatin), Taxol® (paclitaxel), and Avastin® (bevacizumab) is well tolerated and provides clinical benefit in patients with metastatic melanoma,... Continue Reading

More Stage IV Melanoma

Stage IV Pancreatic Cancer

Gemzar plus Avastin Does Not Improve Survival in Advanced Pancreatic Cancer (July 14, 2010)

Afinitor Delays Progression of Advanced Pancreatic Neuroendocrine Tumors (July 8, 2010)

Improved Survival in Metastatic Pancreatic Cancer (June 24, 2010)

AMG 479 Produces Promising Results in Metastatic Pancreatic Cancer (June 7, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

More Stage IV Pancreatic Cancer

Stage IV Rectal Cancer

Radioembolization plus Fluorouracil Active in Colorectal Cancer Patients with Liver Metastases (July 2, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

Vectibix Improves Outcome of Previously Treated Colorectal Cancer (January 27, 2010)

Review Confirms Effectiveness of Avastin® plus Chemotherapy in Advanced Colorectal Cancer (January 20, 2010)

Among patients with advanced colorectal cancer, the addition of Avastin® (bevacizumab) to chemotherapy improves overall and progression-free survival but also increases side effects. These results were published in the Annals of Oncology. Colorectal... Continue Reading

Home Care Nursing Improves Symptom Management (December 4, 2009)

Among breast and colorectal cancer patients treated with the oral chemotherapy drug Xeloda® (capecitabine), symptom management was better among patients who received home care nursing than among patients who received standard care. These results were... Continue Reading

More Stage IV Rectal Cancer

Stage IV Uterine Cancer

Risk Factors Identified for Uterine Sarcoma Survival (March 8, 2009)

Risk Factors Identified for Uterine Sarcoma Survival Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer. The uterus is located in the abdomen... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

More Stage IV Uterine Cancer

Stage IV/Metastatic Bladder Cancer

Sorry, there are no articles available for this cancer stage.

More Stage IV/Metastatic Bladder Cancer

Stage IV/Recurrent Esophageal Cancer

Depression May Persist With Metastatic Cancer (May 27, 2010)

Xeloda® and Eloxatin® Evaluated in Esophageal and Gastric Cancers (March 8, 2009)

Xeloda® and Eloxatin® Evaluated in Esophageal and Gastric Cancers According to the results of a Phase III clinical trial published in the New England Journal of Medicine, it may be possible to replace 5-FU (5-fluorouracil) with Xeloda® (capecitabine)... Continue Reading

More Stage IV/Recurrent Esophageal Cancer

Stages 0-I Bladder Cancer

Sorry, there are no articles available for this cancer stage.

More Stages 0-I Bladder Cancer

Stages I-II Anal Cancer

No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)

More Stages I-II Anal Cancer

Stages I-II Gastric Cancer

Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (March 8, 2009)

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer Among patients diagnosed with gastric (stomach) cancer, a combination of antibiotics against the bacterium Helicobacter pylori (H. pylori) significantly reduces the risk... Continue Reading

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (March 8, 2009)

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. These results were recently published in... Continue Reading

Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer (March 8, 2009)

Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer A combination of chemotherapy and immunotherapy (chemoimmunotherapy) may improve overall survival among gastric cancer patients. These findings were recently published in the... Continue Reading

Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer (March 8, 2009)

Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer An important enzyme known as histone deacetylase may contain useful information about the prognosis of gastric cancer. These findings were recently published in the Lancet. Enzymes... Continue Reading

More Stages I-II Gastric Cancer

Stages I-II Melanoma

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

May Is National Skin Cancer Awareness Month (March 8, 2009)

More Stages I-II Melanoma

Stages I-III Esophageal Cancer

Chemoradiotherapy plus Surgery Improves Esophageal Cancer Survival (July 19, 2010)

Less Extensive Treatment Doesn’t Worsen Survival with Early Esophageal Cancer (September 4, 2009)

Among patients with esophageal adenocarcinoma that involves only the innermost lining (mucosa) of the esophagus, treatment to remove just the cancer appears to result in similar overall survival as treatment that removes the entire esophagus. These results... Continue Reading

Elderly Patients with Esophageal Cancer Can Tolerate Chemoradiotherapy (March 8, 2009)

Elderly Patients with Esophageal Cancer Can Tolerate Chemoradiotherapy Chemoradiotherapy (CRT) is an effective treatment and does not present major toxicity for elderly patients with esophageal cancer, according to the results of a study released in an... Continue Reading

More Stages I-III Esophageal Cancer

Stages I-III Liver Cancer

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (March 8, 2009)

Nexavar® Effective for Hepatocellular Carcinoma in Asians (March 8, 2009)

More Stages I-III Liver Cancer

Stages I-III Pancreatic Cancer

November Is National Pancreatic Cancer Awareness Month (November 5, 2009)

Chemotherapy Improves Pancreatic Cancer Survival (September 9, 2009)

Among patients with inoperable pancreatic cancer, Gemzar® (gemcitabine)-based chemotherapy results in longer survival and better quality of life than an alternative treatment regimen consisting of enzyme therapy, nutritional supplements, detoxification,... Continue Reading

Pancreatic Cancer Care Is Inconsistent (July 21, 2009)

The quality of care for pancreatic cancer varies considerably among hospitals in the United States, according to the results of a study published in the Journal of the National Cancer Institute.[1] Pancreatic cancer has one of the highest mortality rates... Continue Reading

Neoadjuvant Radiation Improves Survival in Pancreatic Cancer (March 8, 2009)

Neoadjuvant Radiation Improves Survival in Pancreatic Cancer Preoperative radiation nearly doubles the survival rate for patients with operable pancreatic cancer, according to the results of a study published in the November 15, 2008 issue of the International... Continue Reading

EndoTAG™-1 Shows Promise in Treatment of Pancreatic Cancer (March 8, 2009)

EndoTAG™-1 Shows Promise in Treatment of Pancreatic Cancer According to the results of a Phase II clinical trial, the addition of the investigational drug EndoTAG™-1 to chemotherapy with Gemzar® (gemcitabine) may improve survival among patients with... Continue Reading

More Stages I-III Pancreatic Cancer

Stages I-III Rectal Cancer

Pathological Complete Response Predicts Better Outcomes in Locally Advanced Rectal Cancer Patients (August 25, 2010)

Antibiotic Sponge Ineffective at Preventing Surgical Infection (August 12, 2010)

Physical Activity Improves Survival of Men with Localized Colorectal Cancer (December 23, 2009)

Home Care Nursing Improves Symptom Management (December 4, 2009)

Aspirin May Improve Survival in Colon Cancer (August 17, 2009)

Regular aspirin use after a colorectal cancer diagnosis may reduce the risk of dying from the disease, especially among tumors that overexpress the COX-2 enzyme, according to the results of a study published in the Journal of the American Medical Association.[1] Previous... Continue Reading

More Stages I-III Rectal Cancer

Stages I-III Uterine Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Laparoscopic Hysterectomy for Endometrial Cancer Associated with Better Quality of Life (August 3, 2010)

Laparoscopic hysterectomy for endometrial cancer that is confined to the uterus is associated with less pain, shorter hospital stays, faster recovery, and better quality of life when compared with total abdominal hysterectomy, according to the results... Continue Reading

Adjuvant Radiation Therapy May Improve Survival in Stage III Uterine Cancer (October 22, 2009)

Among women with node-positive Stage III uterine cancer, use of adjuvant (post-surgery) radiation therapy appears to improve survival. These results were published in Gynecologic Oncology. Stage III uterine cancer extends outside the uterus but remains... Continue Reading

Removal of Ovaries May Not Be Necessary in Young Women with Endometrial Cancer (March 8, 2009)

Removal of Ovaries May Not Be Necessary in Young Women with Endometrial Cancer According to the results of a study published in the Journal of Clinical Oncology, removal of the ovaries may not be necessary in young women treated with hysterectomy for... Continue Reading

Pelvic Lymphadenectomy Does Not Improve Survival in Stage I Endometrial Cancer (March 8, 2009)

Pelvic Lymphadenectomy Does Not Improve Survival in Stage I Endometrial Cancer Pelvic lymphadenectomy (removal of pelvic lymph nodes) may be valuable for staging in endometrial cancer; however, it does not improve survival rates in women with Stage I... Continue Reading

More Stages I-III Uterine Cancer

Stages I-IIIA Lung Cancer - Non-Small Cell

Selenium Does Not Prevent Second Lung Cancers in Patients with Early Non-small Cell Lung Cancer (June 8, 2010)

Supplementation with selenium in patients with Stage IA and IB non-small cell lung cancer does not appear to prevent a second primary lung cancer from developing, according to the results of a Phase III study presented at the 2010 annual meeting of the... Continue Reading

Stereotactic Radiation May Benefit Early Non–Small Cell Lung Cancer Patients Ineligible for Surgery (May 25, 2010)

Patients with early-stage non–small cell lung cancer (NSCLC) who were medically unable to undergo surgery to remove their cancer had a 55.8% overall survival at three years following stereotactic body radiation therapy. These findings were recently... Continue Reading

November Is National Lung Cancer Awareness Month (November 6, 2009)

Large-scale Screening for EGFR Mutations Can Improve Outcomes in Lung Cancer (August 31, 2009)

Large-scale screening for epidermal growth factor receptor mutations in lung cancer is feasible and allows for customization of treatment with Tarceva® (erlotinib), thereby improving outcomes, according to the results of a study published in the New... Continue Reading

PET/CT Improves Detection of Inoperable Lung Cancer (July 3, 2009)

Preoperative lung cancer staging with combined PET/CT imaging allows some patients to avoid futile surgery. These results were published in the New England Journal of Medicine. Lung cancer remains the leading cause of cancer death in the United States.... Continue Reading

More Stages I-IIIA Lung Cancer - Non-Small Cell

Stages II-III Bladder Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

More Stages II-III Bladder Cancer

Stages II-III Breast Cancer

Study Evaluates Impact of Lymph Node Removal in Early-stage Breast Cancer (August 13, 2010)

Updated Guidelines Address Hormonal Therapy for Breast Cancer (July 21, 2010)

Many Breast Cancer Patients Taking Adjuvant Hormonal Therapy Stop Treatment Early (July 1, 2010)

Racial Disparity in Breast Cancer Outcomes Among Underinsured (June 30, 2010)

Gene Mutation Increases Risk of Blood Clots in Breast Cancer Patients Taking Tamoxifen (June 29, 2010)

More Stages II-III Breast Cancer

Stages II-III Multiple Myeloma

Velcade® Improves Response Rate After High-dose Melphalan for Myeloma (December 21, 2009)

Revlimid® Delays Progression of Multiple Myeloma (December 18, 2009)

Velcade® Approved for Initial Therapy of Multiple Myeloma (March 8, 2009)

Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma (March 8, 2009)

Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma According to results recently presented at the 2007 annual meeting of the American Society of Hematology, additional evidence confirms that the addition of Thalomid®... Continue Reading

Velcade® Combinations for Newly Diagnosed Patients with Multiple Myeloma at ASH 2008 (March 8, 2009)

Velcade® Combinations for Newly Diagnosed Patients with Multiple Myeloma at ASH 2008 At the 2008 meeting of the American Society of Hematology (ASH) in December in San Francisco, there were several oral presentations on the outcomes of newly diagnosed... Continue Reading

More Stages II-III Multiple Myeloma

Stages II-IVA Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (June 8, 2009)

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

More Stages II-IVA Cervical Cancer

Stages III-IV Gastric Cancer

Afinitor Promising in Treatment of Advanced Gastric Cancer (July 23, 2010)

Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)

Depression May Persist With Metastatic Cancer (May 27, 2010)

Avastin Fails to Prolong Survival in Stomach Cancer (February 25, 2010)

Avastin® (bevacizumab) in combination with chemotherapy does not extend overall survival in patients with inoperable, advanced or metastatic stomach cancer, according to the results of a phase III trial released by Roche.[i] Stomach cancer, also known... Continue Reading

Herceptin Improves Outcome of HER2-positive Stomach Cancer (October 3, 2009)

According to the results of a Phase III clinical trial, treatment with the targeted therapy Herceptin® (trastuzumab) improves survival among patients with HER2-positive, advanced and inoperable stomach cancer. These results were presented at a major... Continue Reading

More Stages III-IV Gastric Cancer

Stages IIIB-IV Lung Cancer - Non-Small Cell

Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)

Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)

Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)

Combination Chemotherapy Improves Survival in Elderly Lung Cancer Patients (June 7, 2010)

Among patients age 70 or older with advanced non-small cell lung cancer (NSCLC), treatment with a combination of two chemotherapy drugs—paclitaxel and carboplatin—results in better progression-free and overall survival than treatment with single-agent... Continue Reading

Large Study Indicates No Benefit of Shark Cartilage Derivative in Lung Cancer (June 7, 2010)

A randomized Phase III study indicates that the addition of AE-941, a shark cartilage derivative, to standard chemoradiotherapy does not improve survival in patients with unresectable Stage III non–small cell lung cancer (NSCLC). These findings were... Continue Reading

More Stages IIIB-IV Lung Cancer - Non-Small Cell

Stem Cell Transplant

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Statins May Reduce Acute Graft-versus-host Disease (March 8, 2009)

More Stem Cell Transplant

Supportive

Sorry, there are no articles available for this cancer stage.

More Supportive

Supportive Care

Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)

Randomized Study Does Not Support Use of Methylphenidate for Cancer-related Fatigue (August 20, 2010)

The results of a Phase III study indicate that overall, long-acting methylphenidate is ineffective in the management of cancer-related fatigue. Methylphenidate may provide some benefit, however, to certain subgroups of patients, such as those with advanced... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Yoga Improves Sleep and Quality of Life (May 26, 2010)

More Supportive Care

Supportive Care Breast Cancer

Exercise and Green Tea May Help Breast Cancer Survivors Beat the Blues (January 28, 2010)

Exercising and drinking green tea may help prevent depression among breast cancer survivors, according to the results of a study published in the Journal of Clinical Oncology.[1] Depression is a major concern among breast cancer patients and survivors.... Continue Reading

Home Care Nursing Improves Symptom Management (December 4, 2009)

Lifestyle Factors Increase Risk of Second Breast Cancer (September 24, 2009)

Weight Lifting May Be Safe for Breast Cancer Survivors with Lymphedema (August 13, 2009)

Among breast cancer survivors with stable lymphedema, a program of twice-weekly, slowly progressive weight lifting increased strength and reduced lymphedema symptoms without affecting arm and hand swelling. These results were published in the New England... Continue Reading

Breast Cancer Patients Use Antioxidant Supplements During Treatment (July 16, 2009)

Although the consequences of supplementing with antioxidants during cancer treatment remain unknown, many patients with breast cancer continue to use the supplements in an effort to maintain health and diminish the side effects of treatment, according... Continue Reading

More Supportive Care Breast Cancer

Sorry, there are no articles available for this cancer stage.

More T

T-Cell Non-Hodgkin's Lymphoma

Istodax Active against Refractory Cutaneous T-cell Lymphoma (August 31, 2010)

Allogeneic Stem Cell Transplantation Effective for Angioimmunoblastic T-Cell Lymphoma (July 28, 2009)

Among patients with a type of T-cell non-Hodgkin’s lymphoma known as angioimmunoblastic T-cell lymphoma (AITL), treatment with allogeneic stem cell transplantation results in long-term disease-free survival in approximately 50% of patients. The results... Continue Reading

Pralextrate Continues to Show Benefit in Treatment of Peripheral T-Cell Lymphoma (March 8, 2009)

Pralextrate Continues to Show Benefit in Treatment of Peripheral T-Cell Lymphoma According to the final results of a Phase II clinical trial, 27% of patients with relapsed or refractory peripheral T-cell lymphoma (a type of non-Hodgkin’s lymphoma)... Continue Reading

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (March 8, 2009)

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia (March 8, 2009)

More T-Cell Non-Hodgkin's Lymphoma

Testicular Cancer

New Genes Linked to Testicular Cancer (June 28, 2010)

More Testicular Cancer

Throat Cancer

Sorry, there are no articles available for this cancer stage.

More Throat Cancer

Thyroid Cancer

Vandetanib Delays Progression of Advanced Medullary Thyroid Cancer (July 16, 2010)

Childhood Cancer Survivors at Risk for Thyroid Cancer (November 2, 2009)

Targeted Radiotherapy Shows Promise for Iodine-refractory Thyroid Cancer (May 18, 2009)

According to results from a Phase II clinical trial, use of targeted radiation therapy with [90Yttrium-DOTA]-TOC may improve outcomes among patients with iodine-refractory, metastatic thyroid cancer. These results were published in Cancer. The thyroid... Continue Reading